<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD Journal Publishing DTD v2.3 20070202//EN" "journalpublishing.dtd">
<article article-type="research-article" dtd-version="2.3" xml:lang="EN" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">
<front>
<journal-meta>
<journal-id journal-id-type="publisher-id">Front. Mol. Biosci.</journal-id>
<journal-title>Frontiers in Molecular Biosciences</journal-title>
<abbrev-journal-title abbrev-type="pubmed">Front. Mol. Biosci.</abbrev-journal-title>
<issn pub-type="epub">2296-889X</issn>
<publisher>
<publisher-name>Frontiers Media S.A.</publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="publisher-id">1635564</article-id>
<article-id pub-id-type="doi">10.3389/fmolb.2025.1635564</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Molecular Biosciences</subject>
<subj-group>
<subject>Original Research</subject>
</subj-group>
</subj-group>
</article-categories>
<title-group>
<article-title>Three semi-synthetic approaches to a set of curdlan sulfate polysaccharides with different sulfation patterns</article-title>
<alt-title alt-title-type="left-running-head">Esposito et al.</alt-title>
<alt-title alt-title-type="right-running-head">
<ext-link ext-link-type="uri" xlink:href="https://doi.org/10.3389/fmolb.2025.1635564">10.3389/fmolb.2025.1635564</ext-link>
</alt-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname>Esposito</surname>
<given-names>Fabiana</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
<uri xlink:href="https://loop.frontiersin.org/people/3080482/overview"/>
<role content-type="https://credit.niso.org/contributor-roles/conceptualization/"/>
<role content-type="https://credit.niso.org/contributor-roles/methodology/"/>
<role content-type="https://credit.niso.org/contributor-roles/investigation/"/>
<role content-type="https://credit.niso.org/contributor-roles/Writing - review &#x26; editing/"/>
<role content-type="https://credit.niso.org/contributor-roles/resources/"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Zab&#x142;ocka</surname>
<given-names>Agnieszka</given-names>
</name>
<xref ref-type="aff" rid="aff2">
<sup>2</sup>
</xref>
<role content-type="https://credit.niso.org/contributor-roles/investigation/"/>
<role content-type="https://credit.niso.org/contributor-roles/methodology/"/>
<role content-type="https://credit.niso.org/contributor-roles/writing-original-draft/"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Traboni</surname>
<given-names>Serena</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
<role content-type="https://credit.niso.org/contributor-roles/conceptualization/"/>
<role content-type="https://credit.niso.org/contributor-roles/Writing - review &#x26; editing/"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Iadonisi</surname>
<given-names>Alfonso</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
<uri xlink:href="https://loop.frontiersin.org/people/1900452/overview"/>
<role content-type="https://credit.niso.org/contributor-roles/Writing - review &#x26; editing/"/>
<role content-type="https://credit.niso.org/contributor-roles/conceptualization/"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname>G&#xf3;rska</surname>
<given-names>Sabina</given-names>
</name>
<xref ref-type="aff" rid="aff2">
<sup>2</sup>
</xref>
<uri xlink:href="https://loop.frontiersin.org/people/344592/overview"/>
<role content-type="https://credit.niso.org/contributor-roles/conceptualization/"/>
<role content-type="https://credit.niso.org/contributor-roles/Writing - review &#x26; editing/"/>
<role content-type="https://credit.niso.org/contributor-roles/methodology/"/>
</contrib>
<contrib contrib-type="author" corresp="yes">
<name>
<surname>Bedini</surname>
<given-names>Emiliano</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
<xref ref-type="corresp" rid="c001">&#x2a;</xref>
<uri xlink:href="https://loop.frontiersin.org/people/1244163/overview"/>
<role content-type="https://credit.niso.org/contributor-roles/funding-acquisition/"/>
<role content-type="https://credit.niso.org/contributor-roles/project-administration/"/>
<role content-type="https://credit.niso.org/contributor-roles/writing-original-draft/"/>
<role content-type="https://credit.niso.org/contributor-roles/conceptualization/"/>
<role content-type="https://credit.niso.org/contributor-roles/methodology/"/>
</contrib>
</contrib-group>
<aff id="aff1">
<sup>1</sup>
<institution>Department of Chemical Sciences, University of Naples Federico II, Complesso Universitario Monte S.Angelo</institution>, <addr-line>Napoli</addr-line>, <country>Italy</country>
</aff>
<aff id="aff2">
<sup>2</sup>
<institution>L. Hirszfeld Institute of Immunology and Experimental Therapy, Polish Academy of Sciences</institution>, <addr-line>Wroc&#x142;aw</addr-line>, <country>Poland</country>
</aff>
<author-notes>
<fn fn-type="edited-by">
<p>
<bold>Edited by:</bold> <ext-link ext-link-type="uri" xlink:href="https://loop.frontiersin.org/people/89814/overview">Mattheos Koffas</ext-link>, Rensselaer Polytechnic Institute, United States</p>
</fn>
<fn fn-type="edited-by">
<p>
<bold>Reviewed by:</bold> <ext-link ext-link-type="uri" xlink:href="https://loop.frontiersin.org/people/938281/overview">Gopinath Mummaleti</ext-link>, University of Georgia, United States</p>
<p>
<ext-link ext-link-type="uri" xlink:href="https://loop.frontiersin.org/people/1293867/overview">Zheng Qi</ext-link>, Harbin University of Commerce, China</p>
<p>
<ext-link ext-link-type="uri" xlink:href="https://loop.frontiersin.org/people/3086688/overview">Tianbo Liu</ext-link>, Heilongjiang University of Chinese Medicine, China</p>
<p>
<ext-link ext-link-type="uri" xlink:href="https://loop.frontiersin.org/people/3098281/overview">Xiaopeng Zou</ext-link>, Jiangnan University, China</p>
</fn>
<corresp id="c001">&#x2a;Correspondence: Emiliano Bedini, <email>ebedini@unina.it</email>
</corresp>
</author-notes>
<pub-date pub-type="epub">
<day>10</day>
<month>09</month>
<year>2025</year>
</pub-date>
<pub-date pub-type="collection">
<year>2025</year>
</pub-date>
<volume>12</volume>
<elocation-id>1635564</elocation-id>
<history>
<date date-type="received">
<day>26</day>
<month>05</month>
<year>2025</year>
</date>
<date date-type="accepted">
<day>25</day>
<month>07</month>
<year>2025</year>
</date>
</history>
<permissions>
<copyright-statement>Copyright &#xa9; 2025 Esposito, Zab&#x142;ocka, Traboni, Iadonisi, G&#xf3;rska and Bedini.</copyright-statement>
<copyright-year>2025</copyright-year>
<copyright-holder>Esposito, Zab&#x142;ocka, Traboni, Iadonisi, G&#xf3;rska and Bedini</copyright-holder>
<license xlink:href="http://creativecommons.org/licenses/by/4.0/">
<p>This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.</p>
</license>
</permissions>
<abstract>
<sec>
<title>Introduction</title>
<p>Curdlan is a linear homopolysaccharide composed of &#x3b2;-1&#x2192;3-linked glucose units. It is extracted from some bacteria as an exopolysaccharide and employed in the food industry due to its remarkable rheological and thermal behaviors. Furthermore, its ability to form gel encapsulations with several drugs and its roles in innate and adaptive immunity have fueled an increasing interest in pharmaceutical applications of curdlan and its derivatives. Among them, curdlan sulfate derivatives disclosed not only a highly enhanced water solubility concerning native curdlan but also an efficient immunomodulatory potential in both <italic>in vitro</italic> and <italic>in vivo</italic> assays.</p>
</sec>
<sec>
<title>Methods</title>
<p>To detect the effects of the sulfation degree and sulfation pattern on the immunological activity of curdlan sulfate, a set of regioselectively sulfated curdlan polysaccharides was semi-synthesized and fully characterized utilizing nuclear magnetic resonance (NMR) spectroscopy techniques.</p>
</sec>
<sec>
<title>Results</title>
<p>Although some regioselectively sulfated curdlan derivatives were already reported some years ago, in this work, a comprehensive semi-synthetic study was developed by investigating three different, complementary approaches based on direct regioselective sulfation or desulfation reactions or multistep protection&#x2013;sulfation&#x2013;deprotection procedures.</p>
</sec>
<sec>
<title>Discussion</title>
<p>Some of the semi-synthesized curdlan sulfate derivatives were selected as representatives of different sulfation degrees and patterns and subjected to a panel of immunological assays to define some structure&#x2013;activity relationships.</p>
</sec>
</abstract>
<kwd-group>
<kwd>glycans</kwd>
<kwd>curdlan</kwd>
<kwd>semi-synthesis</kwd>
<kwd>regioselective sulfation</kwd>
<kwd>sulfation pattern</kwd>
<kwd>immunological assays</kwd>
</kwd-group>
<contract-num rid="cn001">E53D23020320001</contract-num>
<contract-sponsor id="cn001">Ministero Dell&#x2019;Universit&#xe0; e Della Ricerca<named-content content-type="fundref-id">10.13039/501100021856</named-content>
</contract-sponsor>
<custom-meta-wrap>
<custom-meta>
<meta-name>section-at-acceptance</meta-name>
<meta-value>Glycoscience</meta-value>
</custom-meta>
</custom-meta-wrap>
</article-meta>
</front>
<body>
<sec id="s1">
<title>1 Introduction</title>
<p>Curdlan is a biopolymer extracted from some bacteria, with a homopolysaccharide structure composed of &#x3b2;-1&#x2192;3-linked glucose (Glc) units (<xref ref-type="bibr" rid="B33">McIntosh et al., 2005</xref>). It is currently available in high yield from the fermentation of mutant <italic>Agrobacterium</italic> strains (<xref ref-type="bibr" rid="B27">Kalyanasundaram et al., 2012</xref>; <xref ref-type="bibr" rid="B46">Zhan et al., 2012</xref>). It is mainly used as a food additive due to its remarkable rheological and thermal properties. In addition, a growing interest for the biomedical applications of curdlan (<xref ref-type="bibr" rid="B9">Chaudhari et al., 2021</xref>), particularly in the field of immunology, is due to the identification of the effects of &#x3b2;-glucans in modulating both immune and adaptive responses (<xref ref-type="bibr" rid="B22">Goodridge et al., 2009</xref>) through the recognition by several receptors, including complement receptor-3 (CR3), Toll-like receptors-2, 4, and 6 (TLR2, TLR4, and TLR6), and dectin-1 (<xref ref-type="bibr" rid="B46">Zhan et al., 2012</xref>).</p>
<p>The biomedical properties of native curdlan have fueled increasing efforts in accessing several derivatives thereof with defined structural modifications (<xref ref-type="bibr" rid="B11">Chen and Wang, 2020</xref>; <xref ref-type="bibr" rid="B19">Ganie et al., 2022</xref>; <xref ref-type="bibr" rid="B47">Zhang and Edgar, 2014</xref>). The most investigated derivatizations on curdlan are the insertion of sulfate and carboxymethyl groups, as they can highly increase the water solubility of the native polysaccharide. Moreover, it has been reported that sulfated curdlan derivatives are able to activate dendritic cells mainly through the TLR2 and TLR4 signaling pathways, and this results in a remarkable adjuvant activity in antitumor and hepatitis B virus immunotherapy both <italic>in vitro</italic> and <italic>in vivo</italic> (<xref ref-type="bibr" rid="B26">Jin et al., 2020</xref>; <xref ref-type="bibr" rid="B31">Li et al., 2014</xref>).</p>
<p>Sulfated curdlan is a representative of the family of the so-called engineered sulfated polysaccharides (ESPs) (<xref ref-type="bibr" rid="B3">Arlov et al., 2021</xref>) that are obtained through chemical, enzymatic, or chemo-enzymatic sulfation of native, unsulfated polysaccharides in order to impart novel and augmented biological properties compared to the latter (<xref ref-type="bibr" rid="B7">Caputo et al., 2019</xref>; <xref ref-type="bibr" rid="B43">Wang et al., 2018</xref>; <xref ref-type="bibr" rid="B45">Zeng et al., 2019</xref>). ESPs are typically obtained by random sulfation reactions in which the regioselectivity of the installed sulfate groups within the repeating unit of the polysaccharide cannot be controlled. However, in the recent years, research workers have put intense efforts into developing methods for the regioselective sulfation of polysaccharides (<xref ref-type="bibr" rid="B6">Bedini et al., 2017</xref>). The main reason is that ESPs could act in biological events as analogs of glycosaminoglycans (GAGs), which are sulfated polysaccharides widespread in nature and, above all, in mammals, including humans (<xref ref-type="bibr" rid="B34">Perez et al., 2023</xref>). GAGs are able to encode a variety of biological information and, therefore, play key roles in a plethora of physiopathological processes, such as immunity, angiogenesis, cancer, and infectious diseases, through their sulfation pattern, that is, the distribution of the sulfate groups along their polysaccharide backbone (<xref ref-type="bibr" rid="B37">Ricard-Blum et al., 2024</xref>).</p>
<p>The regioselective installation of sulfate groups on polysaccharides through chemical methods relies upon three main strategies: (i) sulfation of the most reactive hydroxyls through direct reactions under conditions that are mild enough to control the regioselectivity, (ii) desulfation of the most reactive sulfate groups on a previously obtained persulfated polysaccharide derivative, and (iii) multistep methods based on the regioselective installation of suitable protecting groups on some of the hydroxyls of the polysaccharide, followed by sulfation of the unprotected positions and then by cleavage of the previously installed protecting groups (<xref ref-type="bibr" rid="B6">Bedini et al., 2017</xref>). Few scattered examples of these different approaches toward the access to regioselectively sulfated curdlan derivatives can be found in literature (<xref ref-type="bibr" rid="B8">Chaidedgumjorn et al., 2002</xref>; <xref ref-type="bibr" rid="B20">Gao et al., 1997</xref>; <xref ref-type="bibr" rid="B41">Vessella et al., 2021a</xref>; <xref ref-type="bibr" rid="B44">Yoshida et al., 1995</xref>). In this work, we report a comprehensive investigation of the three strategies as complementary approaches to a set of sulfated curdlan polysaccharide derivatives with different sulfation patterns. The chemical structure of all the obtained products was fully characterized by 1D- and 2D-NMR spectroscopy techniques. Finally, some of them were selected as representatives of different sulfation degrees (DSs) and patterns (respectively intended as the average number of sulfate groups per polysaccharide repeating unit and their distribution among the different sites within the repeating unit) and subjected to a panel of immunological assays in order to define some structure&#x2013;activity relationships.</p>
</sec>
<sec sec-type="materials|methods" id="s2">
<title>2 Materials and methods</title>
<sec id="s2-1">
<title>2.1 Materials</title>
<p>Curdlan was purchased from Biosynth. Commercial-grade reagents and solvents for the chemical modification and structural characterization of curdlan were purchased from Avantor and used without further purification. The term &#x201c;pure water&#x201d; refers to water purified by a Millipore Milli-Q Gradient system. High-Glc Dulbecco&#x2019;s modified Eagle&#x2019;s medium (DMEM) was purchased from Gibco. Fetal bovine serum (FBS) and antibiotics (penicillin/streptomycin mixture) were purchased from Biowest. <italic>N</italic>-(1-Naphthyl)-ethylenediamine was purchased from Serva Feinbiochemica. Sulfanilamide, sodium nitrite, sulfuric acid, and orthophosphoric acid were purchased from Avantor. The trypsin&#x2013;EDTA solution and phosphate-buffered saline (PBS) (pH 7.4) were prepared in the General Chemistry Laboratory of the Institute of Immunology and Experimental Therapy, PAS. Bacterial lipopolysaccharide (LPS) obtained from <italic>Escherichia coli</italic> (serotype O55:B5) was prepared in the Laboratory of Microbial Immunochemistry and Vaccines of the Institute of Immunology and Experimental Therapy, PAS. A wild-type mouse bone marrow-derived macrophage (BMDM) cell line (NR-945) was obtained from BEI Resources, NIAID, and the National Institutes of Health (NIH). The human TNF&#x3b1; IL-6 and IL-10 DuoSet ELISA kit was purchased from R&#x26;D Systems. Tween-20, TLR4 ligand ultrapure LPS-EB, and bovine serum albumin (BSA) were purchased from Sigma-Aldrich. TLR2 and TLR4 HEK-Blue&#x2122; cells, the HEK-Blue detection kit, and TLR2 ligand Pam3CSK4 were purchased from InvivoGen. U0126 and SP600125 inhibitors were obtained from Cell Signaling Technology. JSH23 inhibitor and <italic>S-methylisothiourea hemisulfate salt</italic> (S-MIU) were obtained from Sigma-Aldrich.</p>
</sec>
<sec id="s2-2">
<title>2.2 General methods</title>
<p>Centrifugations were performed with an Eppendorf Centrifuge 5804 R instrument at 4 &#xb0;C. Dialysis purifications were conducted on Spectra/Por 3.5 kDa cutoff membranes. Freeze-drying was performed with a 5 Pa Lio 5P 4K freeze dryer. Aliquots of curdlan sulfate derivatives were further purified before immunological assays by sequential filtrations on two Sep-Pak C18 cartridges followed by freeze-drying. NMR spectra were recorded on a Bruker Avance-III HD (<sup>1</sup>H: 400 MHz, <sup>13</sup>C: 100 MHz) or on a Bruker Avance-III (<sup>1</sup>H: 600 MHz, <sup>13</sup>C: 150 MHz) instrument&#x2014;the latter equipped with a cryo-probe&#x2014;in D<sub>2</sub>O [with acetone as the internal standard, <sup>1</sup>H: (CH<sub>3</sub>)<sub>2</sub>CO at &#x3b4; 2.22; <sup>13</sup>C:(<italic>C</italic>H<sub>3</sub>)<sub>2</sub>CO at &#x3b4; 31.5] or DMSO-<italic>d</italic>
<sub>
<italic>6</italic>
</sub> (with solvent isotopic impurity as the internal standard, <sup>1</sup>H: CHD<sub>2</sub>SOCD<sub>3</sub> at &#x3b4; 2.49). Data were processed using the data analysis packages integrated with Bruker TopSpin&#xae; 4.0.5 software. Gradient-selected COSY experiments were performed using spectral widths of 6,000 Hz in both dimensions using datasets of 2,048 &#xd7; 300 points. <sup>1</sup>H, <sup>13</sup>C-DEPT-HSQC experiments were conducted in the <sup>1</sup>H-detected mode via single quantum coherence with proton decoupling in the <sup>13</sup>C domain using datasets of 2,048 &#xd7; 300 points and typically from 64 to 96 increments.</p>
</sec>
<sec id="s2-3">
<title>2.3 Conversion of curdlan into LMW-curdlan</title>
<p>A fine suspension of curdlan (271 mg, 1.67 mmol repeating unit) in pure water (27 mL) was treated with trifluoroacetic acid (TFA, 2.2 mL) and then stirred at 60 &#xb0;C for 3 h. Thereafter, the reaction mixture was neutralized by the addition of a 33% <italic>v</italic>/<italic>v</italic> NaOH solution in pure water. The mixture was dialyzed and then freeze-dried to obtain the low molecular weight polysaccharide (LMW-curdlan, LMW-C) as a white powder (258 mg, 95% mass yield).</p>
</sec>
<sec id="s2-4">
<title>2.4 Conversion of LMW-curdlan into derivative 1</title>
<p>LMW-C (57.2 mg, 0.350 mmol) was suspended in dry <italic>N</italic>,<italic>N</italic>-dimethylformamide (DMF, 2.1 mL) and then treated with benzoic anhydride (Bz<sub>2</sub>O, 396 mg, 1.75 mmol) and <italic>N</italic>,<italic>N</italic>-diisopropylethylamine (DIPEA, 1.23 mL, 7.06 mmol). After overnight stirring at room temperature (rt), diisopropyl ether (10 mL) was added to form a white precipitate that was collected by centrifugation at 4,600 <italic>g</italic> for 5 min at 4 &#xb0;C and then dried under vacuum overnight to obtain derivative <bold>1</bold> (88.4 mg, 154% mass yield).</p>
</sec>
<sec id="s2-5">
<title>2.5 Typical procedure for selective sulfation</title>
<p>LMW-C (62.9 mg, 0.388 mmol) was suspended in dry DMF (2.5 mL; or dry dimethyl sulfoxide, DMSO, 1.2 mL) and then treated with a 1.10 M solution of sulfur trioxide&#x2013;<italic>N</italic>,<italic>N</italic>-dimethylformamide complex (SO<sub>3</sub>&#xb7;DMF; or sulfur trioxide&#x2013;pyridine complex, SO<sub>3</sub>&#xb7;py) in dry DMF (or dry DMSO, 880 &#x3bc;L, 0.970 mmol). After stirring for 75 min (or 3 h) at rt (or at 50 &#xb0;C), the mixture was diluted in pure water (15 mL) and neutralized with sodium carbonate (Na<sub>2</sub>CO<sub>3</sub>). Dialysis, freeze-drying, and further purification of the obtained material by filtration on a Sep-Pak C18 cartridge were followed again by freeze-drying, yielding polysaccharide <bold>CS-4</bold> (108.4 mg, 172% mass yield; or <bold>CS-1&#x2013;3, 57</bold>) as a white amorphous solid.</p>
</sec>
<sec id="s2-6">
<title>2.6 Typical procedure for desulfation</title>
<p>Persulfated LMW-C polysaccharide (<bold>CS-6</bold>, 26.1 mg, 70.3 &#x3bc;mol) was dissolved in pure water (3.0 mL) and eluted through a short plug of freshly activated Dowex-H<sup>&#x2b;</sup> resin with pure water. The eluate was neutralized with pyridine (py) and freeze-dried to produce a residue (26.3 mg) that was dissolved in dry py (3.5 mL) and then treated with <italic>N</italic>-methyl-<italic>N</italic>-(trimethylsilyl)-trifluoroacetamide [MTSTFA, 76 &#x3bc;L, 0.41 mmol; or <italic>N</italic>,<italic>O</italic>-bis(trimethylsilyl)-acetamide, BTSA]. The mixture was stirred at 70 &#xb0;C&#x2013;100 &#xb0;C overnight. The resulting brown mixture was then cooled to rt, diluted with pure water (5 mL), and then dialyzed. The resulting aqueous solution was treated with freshly activated Dowex-H<sup>&#x2b;</sup> resin for some minutes. Thereafter, the resin was filtered off, and the resulting solution was neutralized with a 1 M NaOH aqueous solution and then dialyzed and freeze-dried to obtain <bold>CS-8</bold> (12.0 mg, 46% mass yield; or <bold>CS-9</bold>) as a white amorphous solid.</p>
</sec>
<sec id="s2-7">
<title>2.7 Typical procedure for sulfation of protected, semi-synthetic intermediates and deprotection</title>
<p>Derivative <bold>1</bold> (81.2 mg, 0.310 mmol; or <bold>2</bold> or <bold>4</bold>) was suspended in dry DMF (1.8 mL) and then treated with a 1.15 M solution of SO<sub>3</sub>&#xb7;py in dry DMF (5.3 mL, 6.1 mmol). After stirring overnight at 50&#xb0;C, the mixture was cooled to rt, and then, a saturated NaCl solution in acetone (15 mL) was added. The obtained yellowish precipitate was collected by centrifugation at 4,600 g for 5 min at 4&#xb0;C and then dissolved in pure water (10 mL) and treated with a 33% <italic>v</italic>/<italic>v</italic> NaOH solution in pure water to adjust the pH to 12. The solution was stirred overnight at rt, and then neutralized with a 1 M HCl aqueous solution, dialyzed, and freeze-dried to obtain the derivative <bold>CS-10</bold> (41.9 mg, 52% mass yield; or <bold>CS-11,12</bold>) as a white amorphous solid.</p>
</sec>
<sec id="s2-8">
<title>2.8 Cell culture</title>
<p>BMDM cells were cultured in DMEM containing GlutaMAX supplemented with 10% FBS and a standard antibiotic mix of penicillin and streptomycin according to the supplier&#x2019;s guidelines. Culturing was performed in a humidified incubator at 37 &#xb0;C with 5% CO<sub>2</sub> and 95% air. When the cells reached approximately 90% confluence, they were detached using a trypsin&#x2013;EDTA solution, centrifuged at 150 <italic>g</italic> for 10 min, and then resuspended in fresh growth medium. HEK-Blue&#x2122; cells, human embryonic kidney cell line HEK293 stably co-transfected with secreted embryonic alkaline phosphatase (SEAP), and the human (h) TLR2 and TLR4 were cultured in DMEM with 10% FBS (v/v) and selective antibiotics as required in the handling procedure (InvivoGen) in a humidified atmosphere (5% CO<sub>2</sub>, 95% air) at 37&#xb0;C. The cell cultures were renewed with the use of the PBS and without centrifuging when the confluency reached 80% of the bottle.</p>
</sec>
<sec id="s2-9">
<title>2.9 Assay for cytokine and nitrite/nitrate generation</title>
<p>BMDM cells were seeded in 48-well plates at a density of 1 &#xd7; 10<sup>6</sup> cells/mL and maintained in complete medium for 24 h. The next day, the culture medium was refreshed, and the test compounds were applied alone, simultaneously with LPS (1 &#x3bc;g/mL), or after a 5-h pretreatment period prior to LPS (1 &#x3bc;g/mL) exposure. As a positive control, cells were stimulated with LPS from <italic>Escherichia coli</italic> (serotype O55:B5) applied alone, at a concentration of 1 &#x3bc;g/mL, whereas unstimulated cells served as a negative control. As NO is synthesized by inducible NOS, a selective iNOS inhibitor, i.e., S-MIU (10 &#xb5;M), was used to check the specificity of NO production. Additionally, to determine the impact of ERK 1/2 and JNK kinases and the NF-&#x3ba;B transcription factor activation on the regulation of NO production, BMDM cells were pre-incubated for 1 h with selective kinase inhibitors, namely, U0126 (20 &#xb5;M) (for ERK1/2), SP600125 (20 &#xb5;M), and JSH23 (10 &#xb5;M) (for NF-&#x3ba;B), and then stimulated with particular samples. After 24 h incubation at 37 &#xb0;C in a humidified atmosphere with 5% CO<sub>2</sub>, culture supernatants were collected and centrifuged at 6,000 <italic>g</italic> for 5 min at rt. The clarified supernatants were then used to assess cytokine levels and NO production.</p>
</sec>
<sec id="s2-10">
<title>2.10 Nitric oxide determination</title>
<p>Nitric oxide production was assessed by measuring the nitrite levels in the supernatants of macrophage cell cultures after 24 h incubation with the tested compounds using the Griess reagent colorimetric method (<xref ref-type="bibr" rid="B25">Guevara et al., 1998</xref>). In brief, 100 &#x3bc;L of each cell culture supernatant was mixed with an appropriate volume of Griess reagent [0.1% <italic>N</italic>-(1-naphthyl)-ethylenediamine and 1% sulfanilamide in 5% ortho-phosphoric acid]. After incubation at rt for 10 min, the absorbance was measured at 550 nm. Nitrite concentrations were quantified by comparison with a standard curve prepared with sodium nitrite (NaNO<sub>2</sub>) in the range 0 &#x3bc;M&#x2013;50 &#x3bc;M.</p>
</sec>
<sec id="s2-11">
<title>2.11 ELISA</title>
<p>Cytokines (TNF-&#x3b1;, IL-6, and IL-10) were determined by enzyme-linked immunosorbent assays using human TNF-&#x3b1; DuoSet ELISA according to the manufacturer&#x2019;s recommended procedure.</p>
</sec>
<sec id="s2-12">
<title>2.12 Stimulation of TLR2 and TLR4 receptors</title>
<p>The HEK-Blue&#x2122; TLR receptors cells (&#x223c;140,000 cells/mL) were suspended in HEK-Blue&#x2122; detection medium, seeded in 96-well plates, and stimulated with LMW-C and its derivatives at concentrations of 10 and 100 &#x3bc;g/mL. TLR2 ligand Pam3CSK4 (1 &#x3bc;g/mL) and TLR4 ligand ultrapure LPS-EB (1 &#x3bc;g/mL) were used as the positive controls. The activation of receptors was monitored by determining the real-time hydrolytic activity of the SEAP. The colorimetric reaction developed for 10 h&#x2013;16 h, and the absorbance at 610 nm was measured.</p>
</sec>
</sec>
<sec sec-type="results|discussion" id="s3">
<title>3 Results and discussion</title>
<sec id="s3-1">
<title>3.1 Semi-synthesis of a set of regioselectively sulfated curdlan polysaccharides</title>
<p>The molecular weight (M<sub>w</sub>) estimated for native curdlan ranges from medium to rather high (50&#x2013;1,000 kDa) (<xref ref-type="bibr" rid="B18">Futatsuyama and Ogawa, 1999</xref>). As high-M<sub>w</sub> sulfated polysaccharides can cause adverse effects (<xref ref-type="bibr" rid="B17">Fonseca et al., 2010</xref>), a polysaccharide chain shortening was first performed on curdlan under known, partial acid hydrolysis conditions using 1 M TFA at 60 &#xb0;C for 3 h (<xref ref-type="bibr" rid="B23">Grandpierre et al., 2008</xref>; <xref ref-type="bibr" rid="B35">Prieto et al., 2011</xref>). After dialytic purification, the obtained low-M<sub>w</sub> curdlan polysaccharide (LMW-C) was subjected to regioselective sulfation using three different semi-synthetic approaches.</p>
<p>The first strategy that was investigated in this study was the direct sulfation under mild conditions (<xref ref-type="scheme" rid="sch1">Scheme 1</xref>). To the best of our knowledge, only a single work previously dealt with the direct, regioselective sulfation of curdlan. It reported the quantitative sulfation of the primary hydroxyls at position C-6 on a LMW-C, together with a partial derivatization on the secondary alcohol at some of the C-2 sites (DS-2 &#x3d; 0.52&#x2013;0.55), by employing SO<sub>3</sub>&#xb7;py as the sulfating agent in dimethyl sulfoxide (DMSO) at rt for significantly short reaction times (60 min&#x2013;90 min) (<xref ref-type="bibr" rid="B20">Gao et al., 1997</xref>). In this work, we tested a sulfation of LMW-C under very similar reaction conditions (<xref ref-type="table" rid="T1">Table 1</xref>, entry 1) and then screened the effect of three of the main reaction parameters, such as the solvent and sulfating agent type and amount, in order to find the best conditions for regioselective sulfation at Glc O-6 sites with the highest DS (<xref ref-type="table" rid="T1">Table 1</xref>, entries 3&#x2013;7). In particular, both SO<sub>3</sub>&#xb7;py and SO<sub>3</sub>&#xb7;DMF were tested as sulfating agents in different amounts and in two of the most commonly employed solvents for polysaccharide sulfation reactions, that is, DMSO and DMF (<xref ref-type="bibr" rid="B6">Bedini et al., 2017</xref>).</p>
<fig id="sch1" position="float">
<label>SCHEME 1</label>
<caption>
<p>Semi-synthetic strategies toward regioselectively sulfated CS derivatives relying upon <bold>(a)</bold> multistep approaches, <bold>(b)</bold> selective sulfation, and <bold>(c)</bold> selective desulfation reactions.</p>
</caption>
<graphic xlink:href="FMOLB_fmolb-2025-1635564_wc_sch1.tif">
<alt-text content-type="machine-generated">Scheme illustrating the chemical structures of starting curdlan and the obtained sulfated derivatives thereof as well as the reactions employed for such chemical transformations.</alt-text>
</graphic>
</fig>
<table-wrap id="T1" position="float">
<label>TABLE 1</label>
<caption>
<p>Selective sulfation tests on LMW-C under different reaction conditions (see <xref ref-type="scheme" rid="sch1">Scheme 1</xref>, pathway B).</p>
</caption>
<table>
<thead valign="top">
<tr>
<th align="center">Entry</th>
<th align="center">Product</th>
<th align="center">Conditions</th>
<th align="center">Mass yield (%)</th>
<th align="center">Molar yield<xref ref-type="table-fn" rid="Tfn1">
<sup>a</sup>
</xref> (%)</th>
<th align="center">DS-2</th>
<th align="center">DS-4</th>
<th align="center">DS-6</th>
<th align="center">Total DS<xref ref-type="table-fn" rid="Tfn2">
<sup>b</sup>
</xref>
</th>
</tr>
</thead>
<tbody valign="top">
<tr>
<td align="center">1</td>
<td align="center">
<bold>CS-1</bold>
</td>
<td align="center">SO<sub>3</sub>&#xb7;py (7 equivalents), DMSO, rt, 75 min</td>
<td align="center">107</td>
<td align="center">74</td>
<td align="center">0</td>
<td align="center">0</td>
<td align="center">0.70<xref ref-type="table-fn" rid="Tfn3">
<sup>c</sup>
</xref> (0.69)<xref ref-type="table-fn" rid="Tfn4">
<sup>d</sup>
</xref>
</td>
<td align="center">0.70</td>
</tr>
<tr>
<td align="center">2</td>
<td align="center">
<bold>CS-2</bold>
</td>
<td align="center">SO<sub>3</sub>&#xb7;py (7 equivalents), DMSO, rt, 75 min (x2)</td>
<td align="center">85</td>
<td align="center">59</td>
<td align="center">0</td>
<td align="center">0</td>
<td align="center">0.71<xref ref-type="table-fn" rid="Tfn3">
<sup>c</sup>
</xref>
</td>
<td align="center">0.71</td>
</tr>
<tr>
<td align="center">3</td>
<td align="center">
<bold>CS-3</bold>
</td>
<td align="center">SO<sub>3</sub>&#xb7;DMF (7 equivalents), DMSO, rt, 75 min</td>
<td align="center">84</td>
<td align="center">59</td>
<td align="center">0</td>
<td align="center">0</td>
<td align="center">0.68<xref ref-type="table-fn" rid="Tfn3">
<sup>c</sup>
</xref>
</td>
<td align="center">0.68</td>
</tr>
<tr>
<td align="center">4</td>
<td align="center">
<bold>CS-4</bold>
</td>
<td align="center">SO<sub>3</sub>&#xb7;DMF (2.5 equivalents), DMF, rt, 75 min</td>
<td align="center">172</td>
<td align="center">74</td>
<td align="center">0.52<xref ref-type="table-fn" rid="Tfn5">
<sup>e</sup>
</xref>
</td>
<td align="center">0.60<xref ref-type="table-fn" rid="Tfn6">
<sup>f</sup>
</xref>
</td>
<td align="center">1.00</td>
<td align="center">2.12</td>
</tr>
<tr>
<td align="center">5</td>
<td align="center">
<bold>CS-5</bold>
</td>
<td align="center">SO<sub>3</sub>&#xb7;py (10 equivalents), DMF, rt, 75 min</td>
<td align="center">87</td>
<td align="center">40</td>
<td align="center">0.30<xref ref-type="table-fn" rid="Tfn5">
<sup>e</sup>
</xref>
</td>
<td align="center">0.59<xref ref-type="table-fn" rid="Tfn6">
<sup>f</sup>
</xref>
</td>
<td align="center">1.00</td>
<td align="center">1.89</td>
</tr>
<tr>
<td align="center">6</td>
<td align="center">
<bold>CS-6</bold>
</td>
<td align="center">SO<sub>3</sub>&#xb7;DMF (10 equivalents), DMF, rt, 3 h</td>
<td align="center">150</td>
<td align="center">52</td>
<td align="center">1.00<xref ref-type="table-fn" rid="Tfn5">
<sup>e</sup>
</xref>
</td>
<td align="center">1.00<xref ref-type="table-fn" rid="Tfn6">
<sup>f</sup>
</xref>
</td>
<td align="center">1.00</td>
<td align="center">3.00</td>
</tr>
<tr>
<td align="center">7</td>
<td align="center">
<bold>CS-7</bold>
</td>
<td align="center">SO<sub>3</sub>&#xb7;py (2.5 equivalents), DMSO, 50 &#xb0;C, 3 h</td>
<td align="center">108</td>
<td align="center">89</td>
<td align="center">0</td>
<td align="center">0</td>
<td align="center">0.34<xref ref-type="table-fn" rid="Tfn3">
<sup>c</sup>
</xref>
</td>
<td align="center">0.34</td>
</tr>
</tbody>
</table>
<table-wrap-foot>
<fn id="Tfn1">
<label>
<sup>a</sup>
</label>
<p>Calculated from mass yield using the following equation in order to take into consideration the effect of total DS on the average molecular weight (M<sub>w</sub>) of the repeating unit (RU) in the polysaccharide product: <inline-formula id="inf1">
<mml:math id="m1">
<mml:mrow>
<mml:mi>m</mml:mi>
<mml:mi>o</mml:mi>
<mml:mi>l</mml:mi>
<mml:mi>a</mml:mi>
<mml:mi>r</mml:mi>
<mml:mtext>&#x2009;</mml:mtext>
<mml:mi>y</mml:mi>
<mml:mi>i</mml:mi>
<mml:mi>e</mml:mi>
<mml:mi>l</mml:mi>
<mml:mi>d</mml:mi>
<mml:mo>&#x3d;</mml:mo>
<mml:mi>m</mml:mi>
<mml:mi>a</mml:mi>
<mml:mi>s</mml:mi>
<mml:mi>s</mml:mi>
<mml:mtext>&#x2009;</mml:mtext>
<mml:mi>y</mml:mi>
<mml:mi>i</mml:mi>
<mml:mi>e</mml:mi>
<mml:mi>l</mml:mi>
<mml:mi>d</mml:mi>
<mml:mo>&#xd7;</mml:mo>
<mml:mfrac>
<mml:mrow>
<mml:msub>
<mml:mi>M</mml:mi>
<mml:mi>w</mml:mi>
</mml:msub>
<mml:mtext>&#x2009;</mml:mtext>
<mml:mrow>
<mml:mfenced open="(" close=")" separators="|">
<mml:mrow>
<mml:mi>c</mml:mi>
<mml:mi>u</mml:mi>
<mml:mi>r</mml:mi>
<mml:mi>d</mml:mi>
<mml:mi>l</mml:mi>
<mml:mi>a</mml:mi>
<mml:mi>n</mml:mi>
<mml:mtext>&#x2009;</mml:mtext>
<mml:mi>R</mml:mi>
<mml:mi>U</mml:mi>
</mml:mrow>
</mml:mfenced>
</mml:mrow>
</mml:mrow>
<mml:mrow>
<mml:mfenced open="" close="]" separators="|">
<mml:mrow>
<mml:mrow>
<mml:msub>
<mml:mi>M</mml:mi>
<mml:mi>w</mml:mi>
</mml:msub>
<mml:mtext>&#x2009;</mml:mtext>
<mml:mrow>
<mml:mfenced open="(" close=")" separators="|">
<mml:mrow>
<mml:mi>c</mml:mi>
<mml:mi>u</mml:mi>
<mml:mi>r</mml:mi>
<mml:mi>d</mml:mi>
<mml:mi>l</mml:mi>
<mml:mi>a</mml:mi>
<mml:mi>n</mml:mi>
<mml:mtext>&#x2009;</mml:mtext>
<mml:mi>R</mml:mi>
<mml:mi>U</mml:mi>
</mml:mrow>
</mml:mfenced>
</mml:mrow>
<mml:mo>&#x2b;</mml:mo>
<mml:msub>
<mml:mrow>
<mml:mfenced open="[" close="" separators="|">
<mml:mrow>
<mml:mi>t</mml:mi>
<mml:mi>o</mml:mi>
<mml:mi>t</mml:mi>
<mml:mi>a</mml:mi>
<mml:mi>l</mml:mi>
<mml:mtext>&#x2009;</mml:mtext>
<mml:mi>D</mml:mi>
<mml:mi>S</mml:mi>
<mml:mo>&#xd7;</mml:mo>
<mml:mi>M</mml:mi>
</mml:mrow>
</mml:mfenced>
</mml:mrow>
<mml:mi>w</mml:mi>
</mml:msub>
<mml:mtext>&#x2009;</mml:mtext>
<mml:mrow>
<mml:mfenced open="(" close=")" separators="|">
<mml:mrow>
<mml:msubsup>
<mml:mrow>
<mml:mi>S</mml:mi>
<mml:mi>O</mml:mi>
</mml:mrow>
<mml:mn>3</mml:mn>
<mml:mo>&#x2212;</mml:mo>
</mml:msubsup>
<mml:msup>
<mml:mrow>
<mml:mi>N</mml:mi>
<mml:mi>a</mml:mi>
</mml:mrow>
<mml:mo>&#x2b;</mml:mo>
</mml:msup>
</mml:mrow>
</mml:mfenced>
</mml:mrow>
</mml:mrow>
</mml:mrow>
</mml:mfenced>
</mml:mrow>
</mml:mfrac>
<mml:mo>,</mml:mo>
</mml:mrow>
</mml:math>
</inline-formula> with M<sub>w</sub> (curdlan RU) &#x3d; 162 Da and M<sub>w</sub> (SO<sub>3</sub>
<sup>&#x2212;</sup>Na<sup>&#x2b;</sup>) &#x3d; 102 Da.</p>
</fn>
<fn id="Tfn2">
<label>
<sup>b</sup>
</label>
<p>Sum of DS-2, DS-4, and DS-6.</p>
</fn>
<fn id="Tfn3">
<label>
<sup>c</sup>
</label>
<p>Degree of sulfation at position O-6 of the Glc repeating unit, as calculated by relative integration of signals at 4.36 and 3.94 ppm in the 1H-NMR spectrum (see <xref ref-type="fig" rid="F1">Figure 1b</xref>).</p>
</fn>
<fn id="Tfn4">
<label>
<sup>d</sup>
</label>
<p>Degree of sulfation at position O-6 of the Glc repeating unit, as calculated by relative integration of CH<sub>2</sub>-edited signals at &#x3b4;<sub>H/C</sub> 4.36,4.24/68.4 and 3.94,3.76/62.0 ppm in the <sup>1</sup>H, <sup>13</sup>C-DEPT-HSQC spectrum (see <xref ref-type="fig" rid="F1">Figure 1a</xref>).</p>
</fn>
<fn id="Tfn5">
<label>
<sup>e</sup>
</label>
<p>Degree of sulfation at position O-2 of the Glc repeating unit, as calculated by relative integration of the anomeric signals of 2-O-sulfated vs. 2-O-unsulfated Glc residues in the <sup>1</sup>H, <sup>13</sup>C-DEPT-HSQC spectrum (see <xref ref-type="fig" rid="F2">Figure 2</xref>; <xref ref-type="sec" rid="s11">Supplementary Figure S2</xref>).</p>
</fn>
<fn id="Tfn6">
<label>
<sup>f</sup>
</label>
<p>Degree of sulfation at position O-4 of the Glc repeating unit, as calculated by relative integration of the anomeric signals of 2-O-sulfated vs. 2-O-unsulfated Glc residues in the <sup>1</sup>H, <sup>13</sup>C-DEPT-HSQC spectrum (see <xref ref-type="fig" rid="F2">Figure 2</xref>; <xref ref-type="sec" rid="s11">Supplementary Figure S2</xref>).</p>
</fn>
</table-wrap-foot>
</table-wrap>
<p>The obtained set of curdlan sulfate derivatives (<bold>CS-1&#x2013;7</bold>) was subjected to a detailed structural characterization by means of <sup>1</sup>H- and 2D-NMR spectroscopy analysis. For product <bold>CS-1</bold>, sulfate groups were detected exclusively at the Glc O-6 sites, as indicated by its <sup>1</sup>H,<sup>13</sup>C-DEPT-HSQC spectra. Indeed, sulfation is known to induce a 0.7 ppm&#x2013;0.9 ppm and 6 ppm&#x2013;11 ppm downfield shift in the <sup>1</sup>H and <sup>13</sup>C chemical shift values for hydrogen and carbon atoms, respectively, that are directly linked to the oxygen site carrying the sulfate group (<xref ref-type="bibr" rid="B39">Speciale et al., 2022</xref>). In the case of <bold>CS-1</bold>, only CH<sub>2</sub>-edited signals downfield-shifted at <sup>1</sup>H chemical shift values higher than 4.0 ppm, without any CH-edited signal but the anomeric ones in such a range (<xref ref-type="fig" rid="F1">Figure 1a</xref>). A relative integration of a single diastereotopic methylene signal in the <sup>1</sup>H-NMR spectrum for both 6-O-sulfated and unsulfated Glc units at 4.36 and 3.94 ppm, respectively, allowed an estimation of the DS-6 value equal to 0.70. A relative integration of the signals associated with methylene signals of 6-O-sulfated and unsulfated Glc units (at &#x3b4;<sub>H/C</sub> 4.36, 4.24/68.4 and 3.94,3.76/62.0 ppm, respectively) was also performed on the <sup>1</sup>H, <sup>13</sup>C-DEPT-HSQC spectrum of <bold>CS-1</bold>. Notably, the commonly adopted assumption (<xref ref-type="bibr" rid="B15">Esposito et al., 2022</xref>; <xref ref-type="bibr" rid="B42">Vessella et al., 2021b</xref>) that signals associated with the same CH or CH<sub>2</sub> atoms in sulfated and unsulfated units display similar <sup>1</sup>
<italic>J</italic>
<sub>C,H</sub> coupling constants and that a difference of approximately 5 Hz&#x2013;8 Hz from the experimental set value does not cause a substantial variation of the integrated peak volumes (<xref ref-type="bibr" rid="B21">Gargiulo et al., 2009</xref>; <xref ref-type="bibr" rid="B24">Guerrini et al., 2005</xref>) was confirmed to work very well in this case, as a DS-6 value equal to 0.69 was measured from the <sup>1</sup>H, <sup>13</sup>C-DEPT-HSQC spectrum of <bold>CS-1</bold>. DS-6 measurement was performed for <bold>CS-2, 3</bold> and <bold>CS-7</bold> products too as they displayed <sup>1</sup>H-NMR spectra very similar to that of <bold>CS-1</bold> (<xref ref-type="fig" rid="F1">Figure 1b</xref>); DS-6 spanned from 0.34 to 0.71. Notably, no significant modification of the DS-6 value measured for <bold>CS-1</bold> was detected either by repeating the reaction twice under such conditions or by changing the sulfating agent (SO<sub>3</sub>&#xb7;DMF rather than SO<sub>3</sub>&#xb7;py).</p>
<fig id="F1" position="float">
<label>FIGURE 1</label>
<caption>
<p>
<bold>(a)</bold> <sup>1</sup>H- and <sup>1</sup>H, <sup>13</sup>C-DEPT-HSQC NMR spectra (400 MHz, 298 K, D<sub>2</sub>O) of <bold>CS-1</bold> (G &#x3d; Glc, G6S &#x3d; 6-O-sulfated-Glc; DEPT-HSQC signals enclosed in red circles were integrated for DS-6 measurement); <bold>(b)</bold> <sup>1</sup>H-NMR spectra (400 MHz, 298K, D<sub>2</sub>O) of <bold>CS-1,3</bold> and <bold>CS-7</bold> (from bottom to top).</p>
</caption>
<graphic xlink:href="fmolb-12-1635564-g001.tif">
<alt-text content-type="machine-generated">a shows a 2D-NMR spectrum with labeled peaks, marked on a chemical shift scale from 5.5 to 3.0 ppm and 110 to 60 ppm. Graph b illustrates multiple spectra overlaid with varying peak intensities, highlighting differences in the values of the integrated signals.</alt-text>
</graphic>
</fig>
<p>For derivatives <bold>CS-4&#x2013;6</bold>&#x2014;obtained with SO<sub>3</sub>&#xb7;DMF or SO<sub>3</sub>&#xb7;py in DMF rather than in DMSO&#x2014;their <sup>1</sup>H, <sup>13</sup>C-DEPT-HSQC spectra showed methylene signals only at <sup>1</sup>H chemical shift values higher than 4.0 ppm, thus demonstrating an exhaustive sulfation of every primary hydroxyl along the polysaccharide backbone. Moreover, the presence of CH-edited signals comprised in a 4.0 ppm&#x2013;4.6 ppm and 70 ppm&#x2013;80 ppm range of <sup>1</sup>H and <sup>13</sup>C chemical shift values, respectively, clearly suggested the presence of additional sulfate groups derivatizing secondary hydroxyls of the Glc units. In particular, the <sup>1</sup>H, <sup>13</sup>C-DEPT-HSQC spectrum of <bold>CS-6</bold> showed only four non-anomeric CH-signals (<xref ref-type="fig" rid="F2">Figure 2a</xref>), all downfield shifted at <sup>1</sup>H chemical shift values higher than 4.0 ppm (&#x3b4;<sub>H</sub> 4.14, 4.41, 4.42, and 4.46 ppm). Together with the presence of a single anomeric signal at &#x3b4;<sub>H/C</sub> 5.05/100.4 ppm, it revealed that derivative <bold>CS-6</bold> was per-sulfated, with a quantitative derivatization not only at the O-6 position but also at the O-2 and O-4 sites. Conversely, the <sup>1</sup>H, <sup>13</sup>C-DEPT-HSQC spectra of <bold>CS-4</bold> and <bold>CS-5</bold> (<xref ref-type="fig" rid="F2">Figure 2b</xref>; <xref ref-type="sec" rid="s11">Supplementary Figure S2</xref>) showed not only the same signals found for <bold>CS-6</bold> but also some CH-edited signals at <sup>1</sup>H chemical shift values lower than 4.0 ppm. This suggested a non-quantitative derivatization at the O-2 and O-4 positions of Glc units, which could be confirmed by the presence of multiple signals in the anomeric region. With the help of a <sup>1</sup>H,<sup>1</sup>H-homonuclear 2D-NMR spectrum such as COSY (<xref ref-type="sec" rid="s11">Supplementary Figure S3</xref>), anomeric signals could be distinguished between the ones related to the 2-O-sulfated and 2-O-unsulfated Glc units. Indeed, all of them but the most <sup>1</sup>H-downfield shifted one (&#x3b4;<sub>H</sub> 5.13 ppm) formed a cross-peak with non-downfield shifted signals related to H-2 atoms of 2-O-unsulfated Glc units. A complete assignment of the signals in the <sup>1</sup>H, <sup>13</sup>C-DEPT-HSQC spectrum (<xref ref-type="fig" rid="F2">Figure 2b</xref>), supported by literature data (<xref ref-type="bibr" rid="B41">Vessella et al., 2021a</xref>), revealed the presence of tri-, di-, and mono-sulfated Glc units (Glc-2,4,6S, Glc4,6S, and Glc6S). A relative integration of anomeric signals related to 2-O-sulfated vs. 2-O-unsulfated Glc residues afforded an estimation of the DS-2 values indicated in <xref ref-type="table" rid="T1">Table 1</xref> (entries 4 and 5). Similarly, DS-4 values were obtained by relative integration of anomeric signals of 4-O-sulfated vs. 4-O-unsulfated Glc units.</p>
<fig id="F2" position="float">
<label>FIGURE 2</label>
<caption>
<p>
<sup>1</sup>H- and <sup>1</sup>H, <sup>13</sup>C-DEPT-HSQC NMR spectra (400 MHz, 298 K, D<sub>2</sub>O) of <bold>(a) CS-6</bold> and <bold>(b) CS-4</bold> with the assignment of the main signals (G6S &#x3d; 6-O-sulfated-Glc, G4,6S &#x3d; 4,6-di-O-sulfated-Glc, G2,4,6S &#x3d; 2,4,6-tri-O-sulfated-Glc; DEPT-HSQC signals enclosed in gray circles were integrated for DS-2 and DS-4 measurement: see also <xref ref-type="table" rid="T1">Table 1</xref>).</p>
</caption>
<graphic xlink:href="fmolb-12-1635564-g002.tif">
<alt-text content-type="machine-generated">Both a and b show 2D-NMR spectra with labeled peaks, marked on a chemical shift scale from 5.5 to 3.0 ppm and 110 to 60 ppm.</alt-text>
</graphic>
</fig>
<p>The results discussed above showed that a direct sulfation approach allowed the obtainment, as expected, of some CS derivatives that were regioselectively sulfated at their most reactive sites, that is, primary hydroxyls at the Glc C-6 position. Alternative semi-synthetic strategies had to be conducted to obtain CS products showing a complementary sulfation pattern, that is, with sulfate groups exclusively on secondary hydroxyls of the Glc units. Aiming for this, a regioselective desulfation on persulfated curdlan derivative <bold>CS-6</bold> was tested with BTSA or MTSTFA (<xref ref-type="scheme" rid="sch1">Scheme 1c</xref>). These are silylating agents already known to selectively cleave sulfate groups at the O-6 position of several polysaccharides and convert the released primary hydroxyl groups into trimethylsilyl ethers. The latter can then be cleaved in turn by an aqueous work-up to restore the alcohol moieties (<xref ref-type="bibr" rid="B6">Bedini et al., 2017</xref>). BTSA was already reported for desulfation of a persulfated curdlan polysaccharide; nonetheless, the obtained product was analyzed only by <sup>1</sup>H-NMR spectrum, which suggested a non-regioselective reaction (<xref ref-type="bibr" rid="B8">Chaidedgumjorn et al., 2002</xref>). In order to reinvestigate such reactions and also test MTSTFA as an alternative desulfation agent, <bold>CS-6</bold> was converted into its pyridinium salt by treatment with a strong acid resin followed by neutralization with pyridine, and then subjected to reaction with BTSA or MTSTFA in pyridine at a high temperature. After an aqueous work-up, a pyridinium/Na<sup>&#x2b;</sup> cation exchange was performed by treatment with a strong acid resin, followed by neutralization with aqueous NaOH. The obtained products <bold>CS-8, 9</bold> were subjected to detailed structural analysis by <sup>1</sup>H- and 2D-NMR spectroscopy. The reaction with MTSTFA produced <bold>CS-8</bold>, showing two groups of methylene signals in its <sup>1</sup>H, <sup>13</sup>C-DEPT-HSQC NMR spectrum (<xref ref-type="fig" rid="F3">Figure 3a</xref>) at chemical shift values higher or lower than 4.0 ppm, thus corresponding to 6-O-sulfated- and 6-O-desulfated-Glc units, respectively. This demonstrated a non-exhaustive desulfation of the primary positions along the polysaccharide backbone. A relative integration of these signals returned a DS-6 value equal to 0.48 (<xref ref-type="table" rid="T2">Table 2</xref>, entry 1). Conversely, derivative <bold>CS-9</bold> displayed a single group of methylene signals at &#x3b4;<sub>H/C</sub> 3.92, 3.73/62.2 ppm in its <sup>1</sup>H, <sup>13</sup>C-DEPT-HSQC NMR spectrum (<xref ref-type="fig" rid="F3">Figure 3b</xref>). This confirmed the complete 6-O-desulfation of <bold>CS-9</bold> (DS-6 equal to 0), whereas sulfate groups at the secondary positions could still be detected, as evidenced by the presence of CH-edited signals at <sup>1</sup>H chemical shift values higher than 4.0 ppm. In order to gain more insights into the distribution of the residual sulfate groups between the O-2 and O-4 positions of Glc residues, a COSY spectrum (<xref ref-type="sec" rid="s11">Supplementary Figure S4</xref>) was also measured for <bold>CS-9</bold>. With the additional support of literature data (<xref ref-type="bibr" rid="B41">Vessella et al., 2021a</xref>), it was possible to assign each of the four anomeric signals detected in the <sup>1</sup>H, <sup>13</sup>C-DEPT-HSQC NMR spectrum to Glc units with a different sulfate group pattern. In particular, the two more <sup>1</sup>H-downfield shifted anomeric signals were assigned to 2-O-sulfated Glc units, with the one at &#x3b4;<sub>H/C</sub> 5.20/99.0 ppm being related to 2,4-di-O-sulfated-Glc residues, whereas the other at &#x3b4;<sub>H/C</sub> 5.02/101.3 ppm could be assigned to 2-O-sulfated Glc units. Conversely, the two more <sup>1</sup>H-upfield shifted anomeric signals were assigned to 2-O-unsulfated Glc units. In particular, the most <sup>1</sup>H-upfield shifted one (&#x3b4;<sub>H/C</sub> 4.65/104.0 ppm) could be assigned to 4-O-sulfated Glc residues, whereas the one at &#x3b4;<sub>H/C</sub> 4.79/102.4 ppm was related to completely unsulfated Glc units. A relative integration of the four anomeric signals in the <sup>1</sup>H, <sup>13</sup>C-DEPT-HSQC NMR spectrum showed an estimation of the relative amounts of Glc units with different sulfation patterns within the <bold>CS-9</bold> polysaccharide backbone. The more abundant units resulted in 2-O-sulfated and 2,4-di-O-sulfated Glc residues (30% and 37%, respectively), followed by Glc (23%) and 4-O-sulfated-Glc (10%) ones. Such relative values suggested a slightly higher reactivity of the sulfate groups at position C-4 rather than that at C-2 toward desulfation with BTSA, and it was summarized by a DS-2 value higher than the DS-4 one (0.67 vs. 0.47, see <xref ref-type="table" rid="T2">Table 2</xref>, entry 2).</p>
<fig id="F3" position="float">
<label>FIGURE 3</label>
<caption>
<p>
<sup>1</sup>H- and <sup>1</sup>H, <sup>13</sup>C-DEPT-HSQC NMR spectra (400 MHz, 298 K, D<sub>2</sub>O) of <bold>(a) CS-8</bold> and <bold>(b) CS-9</bold> with the assignment of the main signals (G &#x3d; Glc, G2S &#x3d; 2-O-sulfated-Glc, G4S &#x3d; 4-O-sulfated-Glc, G6S &#x3d; 6-O-sulfated-Glc, G2,4S &#x3d; 2,4-di-O-sulfated-Glc, G2,4,6S &#x3d; 2,4,6-tri-O-sulfated-Glc; DEPT-HSQC signals enclosed in gray and red circles were integrated for DS-2, DS-4, and DS-6 measurements).</p>
</caption>
<graphic xlink:href="fmolb-12-1635564-g003.tif">
<alt-text content-type="machine-generated">Both a and b show 2D-NMR spectra with labeled peaks, marked on a chemical shift scale from 5.5 to 3.0 ppm and 110 to 60 ppm.</alt-text>
</graphic>
</fig>
<table-wrap id="T2" position="float">
<label>TABLE 2</label>
<caption>
<p>CS products obtained through desulfation or multistep strategies (see <xref ref-type="scheme" rid="sch1">Scheme 1</xref>, pathways A and C; <xref ref-type="bibr" rid="B41">Vessella et al., 2021a</xref>).</p>
</caption>
<table>
<thead valign="top">
<tr>
<th align="center">Entry</th>
<th align="center">Product</th>
<th align="center">Semi-synthetic strategy</th>
<th align="center">Mass yield (%)</th>
<th align="center">Molar yield (%)</th>
<th align="center">DS-2<xref ref-type="table-fn" rid="Tfn7">
<sup>a</sup>
</xref>
</th>
<th align="center">DS-4<xref ref-type="table-fn" rid="Tfn8">
<sup>b</sup>
</xref>
</th>
<th align="center">DS-6<xref ref-type="table-fn" rid="Tfn9">
<sup>c</sup>
</xref>
</th>
<th align="center">Total DS<xref ref-type="table-fn" rid="Tfn10">
<sup>d</sup>
</xref>
</th>
</tr>
</thead>
<tbody valign="top">
<tr>
<td align="center">1</td>
<td align="center">
<bold>CS-8</bold>
</td>
<td align="center">Desulfation</td>
<td align="center">46<xref ref-type="table-fn" rid="Tfn11">
<sup>e</sup>
</xref>
</td>
<td align="center">76<xref ref-type="table-fn" rid="Tfn12">
<sup>f</sup>
</xref>
</td>
<td align="center">0.34</td>
<td align="center">0.37</td>
<td align="center">0.48</td>
<td align="center">1.19</td>
</tr>
<tr>
<td align="center">2</td>
<td align="center">
<bold>CS-9</bold>
</td>
<td align="center">Desulfation</td>
<td align="center">59<xref ref-type="table-fn" rid="Tfn11">
<sup>e</sup>
</xref>
</td>
<td align="center">99<xref ref-type="table-fn" rid="Tfn12">
<sup>f</sup>
</xref>
</td>
<td align="center">0.67</td>
<td align="center">0.47</td>
<td align="center">0</td>
<td align="center">1.14</td>
</tr>
<tr>
<td align="center">3</td>
<td align="center">
<bold>CS-10</bold>
</td>
<td align="center">Multistep</td>
<td align="center">88<xref ref-type="table-fn" rid="Tfn13">
<sup>g</sup>
</xref>
</td>
<td align="center">55<xref ref-type="table-fn" rid="Tfn14">
<sup>h</sup>
</xref>
</td>
<td align="center">0.54</td>
<td align="center">0.42</td>
<td align="center">0</td>
<td align="center">0.96</td>
</tr>
<tr>
<td align="center">4</td>
<td align="center">
<bold>CS-11</bold>
</td>
<td align="center">Multistep</td>
<td align="center">40<xref ref-type="table-fn" rid="Tfn13">
<sup>g</sup>
</xref>
</td>
<td align="center">19<xref ref-type="table-fn" rid="Tfn14">
<sup>h</sup>
</xref>
</td>
<td align="center">0.20</td>
<td align="center">0.62</td>
<td align="center">1.00</td>
<td align="center">1.82</td>
</tr>
<tr>
<td align="center">5</td>
<td align="center">
<bold>CS-12</bold>
</td>
<td align="center">Multistep</td>
<td align="center">89<xref ref-type="table-fn" rid="Tfn13">
<sup>g</sup>
</xref>
</td>
<td align="center">37<xref ref-type="table-fn" rid="Tfn14">
<sup>h</sup>
</xref>
</td>
<td align="center">0.42</td>
<td align="center">1.00</td>
<td align="center">0.81</td>
<td align="center">2.23</td>
</tr>
<tr>
<td align="center">6<sup>i</sup>
</td>
<td align="center">
<bold>CS-13</bold>
</td>
<td align="center">Multistep</td>
<td align="center">40</td>
<td align="center">21<xref ref-type="table-fn" rid="Tfn14">
<sup>h</sup>
</xref>
</td>
<td align="center">0</td>
<td align="center">0.78</td>
<td align="center">0.66</td>
<td align="center">1.44</td>
</tr>
<tr>
<td align="center">7<sup>i</sup>
</td>
<td align="center">
<bold>CS-14</bold>
</td>
<td align="center">Multistep</td>
<td align="center">69</td>
<td align="center">38<xref ref-type="table-fn" rid="Tfn14">
<sup>h</sup>
</xref>
</td>
<td align="center">0</td>
<td align="center">0.76</td>
<td align="center">0.61</td>
<td align="center">1.33</td>
</tr>
<tr>
<td align="center">8<sup>i</sup>
</td>
<td align="center">
<bold>CS-15</bold>
</td>
<td align="center">Multistep</td>
<td align="center">48</td>
<td align="center">32<xref ref-type="table-fn" rid="Tfn14">
<sup>h</sup>
</xref>
</td>
<td align="center">0</td>
<td align="center">0.35</td>
<td align="center">0.46</td>
<td align="center">0.81</td>
</tr>
<tr>
<td align="center">9<sup>i</sup>
</td>
<td align="center">
<bold>CS-16</bold>
</td>
<td align="center">Multistep</td>
<td align="center">50</td>
<td align="center">28<xref ref-type="table-fn" rid="Tfn14">
<sup>h</sup>
</xref>
</td>
<td align="center">0</td>
<td align="center">0.53</td>
<td align="center">0.69</td>
<td align="center">1.22</td>
</tr>
<tr>
<td align="center">10<sup>i</sup>
</td>
<td align="center">
<bold>CS-17</bold>
</td>
<td align="center">Multistep</td>
<td align="center">46</td>
<td align="center">27<xref ref-type="table-fn" rid="Tfn14">
<sup>h</sup>
</xref>
</td>
<td align="center">0.46</td>
<td align="center">0.12</td>
<td align="center">0.53</td>
<td align="center">1.11</td>
</tr>
<tr>
<td align="center">11<sup>i</sup>
</td>
<td align="center">
<bold>CS-18</bold>
</td>
<td align="center">Multistep</td>
<td align="center">37</td>
<td align="center">26<xref ref-type="table-fn" rid="Tfn14">
<sup>h</sup>
</xref>
</td>
<td align="center">0.49</td>
<td align="center">0</td>
<td align="center">0.16</td>
<td align="center">0.65</td>
</tr>
</tbody>
</table>
<table-wrap-foot>
<fn id="Tfn7">
<label>
<sup>a</sup>
</label>
<p>Degree of sulfation at position O-2 of the Glc repeating unit, as calculated by relative integration of the anomeric signals of 2-O-sulfated vs. 2-O-unsulfated Glc residues in the <sup>1</sup>H, <sup>13</sup>C-DEPT-HSQC spectrum (see <xref ref-type="fig" rid="F3">Figures 3a,b</xref>; <xref ref-type="sec" rid="s11">Supplementary Figures S5, S7, S8</xref>).</p>
</fn>
<fn id="Tfn8">
<label>
<sup>b</sup>
</label>
<p>Degree of sulfation at position O-4 of the Glc repeating unit, as calculated by relative integration of the anomeric signals of 2-O-sulfated vs. 2-O-unsulfated Glc residues in the <sup>1</sup>H, <sup>13</sup>C-DEPT-HSQC spectrum (see <xref ref-type="fig" rid="F3">Figures 3a,b</xref>; <xref ref-type="sec" rid="s11">Supplementary Figures S5, S7, S8</xref>).</p>
</fn>
<fn id="Tfn9">
<label>
<sup>c</sup>
</label>
<p>Degree of sulfation at position O-6 of the Glc repeating unit, as calculated by relative integration of CH<sub>2</sub>-edited signals at &#x3b4;<sub>H/C</sub> 4.36, 4.24/68.4 and 3.94, 3.76/62.0 ppm in the <sup>1</sup>H, <sup>13</sup>C-DEPT-HSQC spectrum (see <xref ref-type="fig" rid="F3">Figure 3A</xref>; <xref ref-type="sec" rid="s11">Supplementary Figures S5, S7, S8</xref>).</p>
</fn>
<fn id="Tfn10">
<label>
<sup>d</sup>
</label>
<p>Sum of DS-2, DS-4, and DS-6.</p>
</fn>
<fn id="Tfn11">
<label>
<sup>e</sup>
</label>
<p>Calculated from the <bold>CS-6</bold> starting amount.</p>
</fn>
<fn id="Tfn12">
<label>
<sup>f</sup>
</label>
<p>Calculated from mass yield using the following equation in order to take into consideration the effect of total DS on the average molecular weight (M<sub>w</sub>) of the repeating unit (RU) in the polysaccharide product: <inline-formula id="inf2">
<mml:math id="m2">
<mml:mrow>
<mml:mi>m</mml:mi>
<mml:mi>o</mml:mi>
<mml:mi>l</mml:mi>
<mml:mi>a</mml:mi>
<mml:mi>r</mml:mi>
<mml:mtext>&#x2009;</mml:mtext>
<mml:mi>y</mml:mi>
<mml:mi>i</mml:mi>
<mml:mi>e</mml:mi>
<mml:mi>l</mml:mi>
<mml:mi>d</mml:mi>
<mml:mo>&#x3d;</mml:mo>
<mml:mi>m</mml:mi>
<mml:mi>a</mml:mi>
<mml:mi>s</mml:mi>
<mml:mi>s</mml:mi>
<mml:mtext>&#x2009;</mml:mtext>
<mml:mi>y</mml:mi>
<mml:mi>i</mml:mi>
<mml:mi>e</mml:mi>
<mml:mi>l</mml:mi>
<mml:mi>d</mml:mi>
<mml:mo>&#xd7;</mml:mo>
<mml:mfrac>
<mml:mrow>
<mml:msub>
<mml:mi>M</mml:mi>
<mml:mi>w</mml:mi>
</mml:msub>
<mml:mtext>&#x2009;</mml:mtext>
<mml:mrow>
<mml:mfenced open="(" close=")" separators="|">
<mml:mrow>
<mml:mi mathvariant="bold-italic">C</mml:mi>
<mml:mi mathvariant="bold-italic">S</mml:mi>
<mml:mn mathvariant="bold">6</mml:mn>
<mml:mtext>&#x2009;</mml:mtext>
<mml:mi>R</mml:mi>
<mml:mi>U</mml:mi>
</mml:mrow>
</mml:mfenced>
</mml:mrow>
</mml:mrow>
<mml:mrow>
<mml:mfenced open="" close="]" separators="|">
<mml:mrow>
<mml:mrow>
<mml:msub>
<mml:mi>M</mml:mi>
<mml:mi>w</mml:mi>
</mml:msub>
<mml:mtext>&#x2009;</mml:mtext>
<mml:mrow>
<mml:mfenced open="(" close=")" separators="|">
<mml:mrow>
<mml:mi>c</mml:mi>
<mml:mi>u</mml:mi>
<mml:mi>r</mml:mi>
<mml:mi>d</mml:mi>
<mml:mi>l</mml:mi>
<mml:mi>a</mml:mi>
<mml:mi>n</mml:mi>
<mml:mtext>&#x2009;</mml:mtext>
<mml:mi>R</mml:mi>
<mml:mi>U</mml:mi>
</mml:mrow>
</mml:mfenced>
</mml:mrow>
<mml:mo>&#x2b;</mml:mo>
<mml:msub>
<mml:mrow>
<mml:mfenced open="[" close="" separators="|">
<mml:mrow>
<mml:mi>t</mml:mi>
<mml:mi>o</mml:mi>
<mml:mi>t</mml:mi>
<mml:mi>a</mml:mi>
<mml:mi>l</mml:mi>
<mml:mtext>&#x2009;</mml:mtext>
<mml:mi>D</mml:mi>
<mml:mi>S</mml:mi>
<mml:mo>&#xd7;</mml:mo>
<mml:mi>M</mml:mi>
</mml:mrow>
</mml:mfenced>
</mml:mrow>
<mml:mi>w</mml:mi>
</mml:msub>
<mml:mtext>&#x2009;</mml:mtext>
<mml:mrow>
<mml:mfenced open="(" close=")" separators="|">
<mml:mrow>
<mml:msubsup>
<mml:mrow>
<mml:mi>S</mml:mi>
<mml:mi>O</mml:mi>
</mml:mrow>
<mml:mn>3</mml:mn>
<mml:mo>&#x2212;</mml:mo>
</mml:msubsup>
<mml:msup>
<mml:mrow>
<mml:mi>N</mml:mi>
<mml:mi>a</mml:mi>
</mml:mrow>
<mml:mo>&#x2b;</mml:mo>
</mml:msup>
</mml:mrow>
</mml:mfenced>
</mml:mrow>
</mml:mrow>
</mml:mrow>
</mml:mfenced>
</mml:mrow>
</mml:mfrac>
<mml:mo>,</mml:mo>
</mml:mrow>
</mml:math>
</inline-formula> with M<sub>w</sub> (<bold>CS-6</bold>) &#x3d; 468 Da, M<sub>w</sub> (curdlan RU) &#x3d; 162 Da and M<sub>w</sub> (SO<sub>3</sub>
<sup>&#x2212;</sup>Na<sup>&#x2b;</sup>) &#x3d; 102 Da.</p>
</fn>
<fn id="Tfn13">
<label>
<sup>g</sup>
</label>
<p>Calculated from the LMW-C starting amount.</p>
</fn>
<fn id="Tfn14">
<label>
<sup>h</sup>
</label>
<p>Calculated from mass yield using the following equation in order to take into consideration the effect of total DS on the average molecular weight (M<sub>w</sub>) of the repeating unit (RU) in the polysaccharide product: <inline-formula id="inf3">
<mml:math id="m3">
<mml:mrow>
<mml:mi>m</mml:mi>
<mml:mi>o</mml:mi>
<mml:mi>l</mml:mi>
<mml:mi>a</mml:mi>
<mml:mi>r</mml:mi>
<mml:mtext>&#x2009;</mml:mtext>
<mml:mi>y</mml:mi>
<mml:mi>i</mml:mi>
<mml:mi>e</mml:mi>
<mml:mi>l</mml:mi>
<mml:mi>d</mml:mi>
<mml:mo>&#x3d;</mml:mo>
<mml:mi>m</mml:mi>
<mml:mi>a</mml:mi>
<mml:mi>s</mml:mi>
<mml:mi>s</mml:mi>
<mml:mtext>&#x2009;</mml:mtext>
<mml:mi>y</mml:mi>
<mml:mi>i</mml:mi>
<mml:mi>e</mml:mi>
<mml:mi>l</mml:mi>
<mml:mi>d</mml:mi>
<mml:mo>&#xd7;</mml:mo>
<mml:mfrac>
<mml:mrow>
<mml:msub>
<mml:mi>M</mml:mi>
<mml:mi>w</mml:mi>
</mml:msub>
<mml:mtext>&#x2009;</mml:mtext>
<mml:mrow>
<mml:mfenced open="(" close=")" separators="|">
<mml:mrow>
<mml:mi>c</mml:mi>
<mml:mi>u</mml:mi>
<mml:mi>r</mml:mi>
<mml:mi>d</mml:mi>
<mml:mi>l</mml:mi>
<mml:mi>a</mml:mi>
<mml:mi>n</mml:mi>
<mml:mtext>&#x2009;</mml:mtext>
<mml:mi>R</mml:mi>
<mml:mi>U</mml:mi>
</mml:mrow>
</mml:mfenced>
</mml:mrow>
</mml:mrow>
<mml:mrow>
<mml:mfenced open="" close="]" separators="|">
<mml:mrow>
<mml:mrow>
<mml:msub>
<mml:mi>M</mml:mi>
<mml:mi>w</mml:mi>
</mml:msub>
<mml:mtext>&#x2009;</mml:mtext>
<mml:mrow>
<mml:mfenced open="(" close=")" separators="|">
<mml:mrow>
<mml:mi>c</mml:mi>
<mml:mi>u</mml:mi>
<mml:mi>r</mml:mi>
<mml:mi>d</mml:mi>
<mml:mi>l</mml:mi>
<mml:mi>a</mml:mi>
<mml:mi>n</mml:mi>
<mml:mtext>&#x2009;</mml:mtext>
<mml:mi>R</mml:mi>
<mml:mi>U</mml:mi>
</mml:mrow>
</mml:mfenced>
</mml:mrow>
<mml:mo>&#x2b;</mml:mo>
<mml:msub>
<mml:mrow>
<mml:mfenced open="[" close="" separators="|">
<mml:mrow>
<mml:mi>t</mml:mi>
<mml:mi>o</mml:mi>
<mml:mi>t</mml:mi>
<mml:mi>a</mml:mi>
<mml:mi>l</mml:mi>
<mml:mtext>&#x2009;</mml:mtext>
<mml:mi>D</mml:mi>
<mml:mi>S</mml:mi>
<mml:mo>&#xd7;</mml:mo>
<mml:mi>M</mml:mi>
</mml:mrow>
</mml:mfenced>
</mml:mrow>
<mml:mi>w</mml:mi>
</mml:msub>
<mml:mtext>&#x2009;</mml:mtext>
<mml:mrow>
<mml:mfenced open="(" close=")" separators="|">
<mml:mrow>
<mml:msubsup>
<mml:mrow>
<mml:mi>S</mml:mi>
<mml:mi>O</mml:mi>
</mml:mrow>
<mml:mn>3</mml:mn>
<mml:mo>&#x2212;</mml:mo>
</mml:msubsup>
<mml:msup>
<mml:mrow>
<mml:mi>N</mml:mi>
<mml:mi>a</mml:mi>
</mml:mrow>
<mml:mo>&#x2b;</mml:mo>
</mml:msup>
</mml:mrow>
</mml:mfenced>
</mml:mrow>
</mml:mrow>
</mml:mrow>
</mml:mfenced>
</mml:mrow>
</mml:mfrac>
<mml:mo>,</mml:mo>
</mml:mrow>
</mml:math>
</inline-formula> with M<sub>w</sub> (curdlan RU) &#x3d; 162 Da and M<sub>w</sub> (SO<sub>3</sub>
<sup>&#x2212;</sup>Na<sup>&#x2b;</sup>) &#x3d; 102 Da.</p>
</fn>
<fn id="Tfn15">
<label>
<sup>i</sup>
</label>
<p>See <xref ref-type="bibr" rid="B41">Vessella et al., 2021a</xref>.</p>
</fn>
</table-wrap-foot>
</table-wrap>
<p>By adopting the same structural characterization approach, an estimation of DS-2 and DS-4 could be conducted for <bold>CS-8</bold> too, revealing very similar values (0.34 and 0.37, respectively), which were also rather close to that of DS-6 (0.48, see <xref ref-type="table" rid="T2">Table 2</xref>, entry 1). This suggested that sulfate groups of 2,4,6-trisulfated-Glc units in persulfated curdlan <bold>CS-6</bold> were cleaved randomly by MTSTFA. Nonetheless, the <sup>1</sup>H, <sup>13</sup>C-DEPT-HSQC spectrum of <bold>CS-8</bold> revealed that the polysaccharide backbone was not constituted by all possible Glc sulfation patterns, as indicated by the presence of only two groups of anomeric signals (<xref ref-type="fig" rid="F3">Figure 3a</xref>). Each of them was associated with two distinct Glc residues, that is, 2,4,6-tri-O-sulfated-Glc and 2,4-di-O-sulfated-Glc residues for more <sup>1</sup>H-downfield shifted signals at &#x3b4;<sub>H/C</sub> 5.16/100.6 and 5.10/100.5 ppm and 6-O-sulfated-Glc and completely unsulfated Glc units for more <sup>1</sup>H-upfield shifted signals at &#x3b4;<sub>H/C</sub> 4.74/103.7 and 4.77/103.4 ppm. This suggested that after the first sulfate group is randomly cleaved from a 2,4,6-tri-O-sulfated Glc unit, the reaction proceeds with some preferences, which are as follows: (i) partially desulfated Glc residues are subjected to further desulfation more easily than the persulfated units because the latter can still be detected in the final product despite the major presence of completely unsulfated Glc units, and (ii) Glc units that were already desulfated at a secondary position are more prone to lose the second sulfate group at a secondary site again, as suggested by the absence of 2,6- and 4,6-disulfated-Glc units and the 2- and 4-sulfated ones, whereas both 2,4-disulfated and 6-sulfated residues can be detected as constituents of the <bold>CS-8</bold> backbone.</p>
<p>The third semi-synthetic strategy employed in this work relied upon protection&#x2013;sulfation&#x2013;deprotection, multistep approaches. One of the selected protecting groups for the first step was triphenylmethyl (trityl, Tr) ether. Its marked steric hindrance could be exploited to protect only the primary alcohol moiety of Glc units, as the latter are known to be more reactive and less sterically hindered than secondary hydroxyls at C-2 and C-4 in curdlan. Tritylation was conducted under homogeneous conditions already reported for curdlan, utilizing trityl chloride and pyridine in a DMF/LiCl system at 70 &#xb0;C to obtain known derivative <bold>2</bold> (<xref ref-type="scheme" rid="sch1">Scheme 1a</xref>) (<xref ref-type="bibr" rid="B13">Chien and Iwata, 2018</xref>). An alternative protecting group that was installed on LMW-C was benzoyl ester (Bz). As it is known to protect not only primary but also secondary hydroxyl moieties, a slight adaptation of an organocatalyzed, site-selective method employed for monosaccharides was tested (<xref ref-type="bibr" rid="B36">Ren et al., 2018</xref>). This relied upon the use of Bz<sub>2</sub>O as the acylating agent in the presence of DIPEA as the organocatalyst. The obtained derivative <bold>1</bold> was analyzed by <sup>1</sup>H-NMR spectroscopy in DMSO-<italic>d</italic>
<sub>
<italic>6</italic>
</sub>, which confirmed the presence of signals in the typical region (8.2-7.0 ppm) for aromatic H atoms of benzoyl esters. Notably, the presence of Bz protecting groups in <bold>1</bold> was further confirmed by the detection of aromatic signals in a diffusion-ordered (1D-DOSY) NMR spectrum (<xref ref-type="sec" rid="s11">Supplementary Figure S1</xref>). Indeed, this allows distinguishing between peaks associated to slowly diffusing macromolecules and signals related to low-molecular-weight contaminants&#x2014;typically faster self-diffusing in solution&#x2014;as only the former are retained in the 1D-DOSY spectrum, whereas the latter are cut off (<xref ref-type="bibr" rid="B5">Bedini et al., 2023</xref>).</p>
<p>Both synthetic intermediates <bold>1</bold> and <bold>2</bold> were subjected to sulfation with SO<sub>3</sub>&#xb7;py in DMF at 50 &#xb0;C, followed by deprotection under aqueous alkaline or acid conditions, respectively, to obtain <bold>CS-10</bold> and <bold>CS-11</bold> derivatives. Moreover, tritylated polysaccharide <bold>2</bold> was also subjected to further protection by acetylation of the secondary hydroxyls with acetic anhydride (Ac<sub>2</sub>O) in pyridine at 50 &#xb0;C to obtain known derivative <bold>3</bold>. The latter was subjected in turn to trityl cleavage with HBr in a chloroform&#x2013;acetic acid mixture. Under these conditions, a concomitant acetyl migration from the C-4 to C-6 site is known to take place (<xref ref-type="bibr" rid="B12">Chien et al., 2017</xref>). Finally, the obtained synthetic intermediate <bold>4</bold> was subjected to sulfation and then acetyl cleavage to obtain product <bold>CS-12</bold>.</p>
<p>The three semi-synthetic derivatives <bold>CS-10&#x2013;12</bold> resulting from multistep sequences were analyzed by <sup>1</sup>H- and 2D-NMR spectroscopy in order to confirm or revise their expected structures (<xref ref-type="scheme" rid="sch1">Scheme 1a</xref>). The <sup>1</sup>H, <sup>13</sup>C-DEPT-HSQC of <bold>CS-10</bold> clearly showed the absence of sulfate groups on any of the primary positions along the polysaccharide backbone, as CH<sub>2</sub>-edited signals appeared exclusively in a region of the spectrum at &#x3b4;<sub>H</sub> lower than 4.0 ppm (<xref ref-type="sec" rid="s11">Supplementary Figure S5</xref>). The presence of several CH-edited signals, downfield shifted at <sup>1</sup>H chemical shift values between 4.3 and 4.6 ppm, suggested that sulfate groups were present instead on the secondary sites of Glc units. This result was in agreement with the putative structure of <bold>CS-10</bold>, thus demonstrating that the multistep approach relying upon the Bz protecting groups was successful. Moreover, the assignment of the main signals in the <sup>1</sup>H, <sup>13</sup>C-DEPT-HSQC spectrum was possible with the help of a COSY spectrum (<xref ref-type="sec" rid="s11">Supplementary Figure S6</xref>) and literature data (<xref ref-type="bibr" rid="B41">Vessella et al., 2021a</xref>). In analogy with the case of products <bold>CS-4, 5</bold> and <bold>CS-8, 9</bold> discussed above, DS-2 and DS-4 values (0.54 and 0.42, respectively: see <xref ref-type="table" rid="T2">Table 2</xref>, entry 3) could be estimated from the relative integration of the distinct anomeric signals at &#x3b4;<sub>H/C</sub> 5.08/100.9, 4.99/101.7, and 4.79/102.4 ppm, which were assigned to 2,4-di-O-sulfated-, 2-O-sulfated-, and unsulfated Glc-CH-1 atoms, respectively. A similar analytical approach was employed for structural characterization of <bold>CS-11</bold> and <bold>CS-12</bold> (<xref ref-type="sec" rid="s11">Supplementary Figures S7, S8</xref>). It resulted in a non-regioselective distribution of sulfate groups among the C-2, C-4, and C-6 sites of Glc units (<xref ref-type="table" rid="T2">Table 2</xref>, entries 4&#x2013;5), thus assessing that the multistep strategies relying upon the Tr protecting groups were unsuccessful.</p>
</sec>
<sec id="s3-2">
<title>3.2 Immunological assays on a set of sulfated curdlan polysaccharides</title>
<p>The eighteen CS derivatives listed in <xref ref-type="table" rid="T1">Tables 1</xref>, <xref ref-type="table" rid="T2">2</xref>, obtained in this work and our previously published report (<xref ref-type="bibr" rid="B41">Vessella et al., 2021a</xref>), represent a significantly comprehensive set of curdlan polysaccharides differentiated for the total DS and the distribution of sulfate groups among the three alcohol positions of Glc units. The use of radar charts, graphically displaying the variation of DS-2, DS-4, DS-6, and total DS (<xref ref-type="fig" rid="F4">Figure 4</xref>), allowed us to select six derivatives (<bold>CS-1, 4, 10, 13, 17,</bold> and <bold>18</bold>) as representatives of different sulfation degrees and patterns. Their structural diversity is crucial as the distribution of the sulfate groups within the Glc repeating unit could significantly influence their biological activity. The selected CS derivatives were, therefore, subjected to a preliminary screening of their immunomodulatory activities in comparison with the starting, unsulfated LMW-C polysaccharide.</p>
<fig id="F4" position="float">
<label>FIGURE 4</label>
<caption>
<p>Radar charts show comparisons among compounds CS-1 to CS-18 across four different criteria (DS-2, DS-4, DS-6 and total DS). Compounds CS-1, CS-4, CS-10, CS-13, CS-17, and CS-18 are highlighted in yellow.</p>
</caption>
<graphic xlink:href="fmolb-12-1635564-g004.tif">
<alt-text content-type="machine-generated">Radar charts show comparisons among compounds CS-1 to CS-18 across four different criteria (DS-2, DS-4, DS-6 and total DS). Compounds CS-1, CS-4, CS-10, CS-13, CS-17, and CS-18 are highlighted in yellow.</alt-text>
</graphic>
</fig>
<p>As the innate immune response is one of the most important components of the body&#x2019;s defenses, our study focused on how macrophages respond to curdlan derivatives. As tissue-resident phagocytes, macrophages play a pivotal role in both innate and adaptive immunity. They are the first line of defense against pathogenic microorganisms, including bacteria and viruses. We conducted experiments using a BMDM cell line isolated from wild-type mice. This model was chosen due to the critical yet still not fully studied role of macrophage responses to unsulfated LMW-C polysaccharides and their derivatives.</p>
<p>A key feature of macrophage activation is the production of NO and cytokines, which are crucial factors of the innate immune response. Cytokines such as TNF-&#x3b1;, IL-6, and IL-10 orchestrate the inflammatory response by modulating the signaling, as well as the recruitment and activation of immune cells (<xref ref-type="bibr" rid="B2">Arango Duque and Descoteaux, 2014</xref>; <xref ref-type="bibr" rid="B10">Chen et al., 2018</xref>). Meanwhile, NO, which is produced via inducible nitric oxide synthase (iNOS), exhibits potent antimicrobial and immunomodulatory properties (<xref ref-type="bibr" rid="B16">Farahani et al., 2025</xref>). It plays a dual role in directly eliminating pathogens and regulating inflammation.</p>
<p>In our studies, the NO level, as measured by nitrite concentration, was determined using the Griess reaction in BMDM cell culture supernatants following treatment with LMW-C and its derivatives <bold>CS-1, 4, 10, 13, 17,</bold> and <bold>18</bold>. The results showed that LMW-C at a dose of 100 &#x3bc;g/mL (but not at 10 &#x3bc;g/mL) had a clear immunomodulatory effect, significantly increasing NO production by BMDM cells to 8.68 &#xb5;M compared to that produced by the control cells. However, none of the tested sulfated derivatives exhibited a similar effect (<xref ref-type="fig" rid="F5">Figure 5A</xref>). Pretreating the BMDM cells with the selective iNOS inhibitor S-MIU significantly inhibited NO production, confirming that the observed effect is under the control of iNOS (<xref ref-type="fig" rid="F6">Figure 6</xref>). It is well known that the transcriptional regulation of the <italic>iNOS</italic> gene is mainly regulated at the transcriptional level due to the activation of mitogen-activated protein kinases (MAPKs) and several transcription factors. Among these, NF-&#x3ba;B activation appears to be the most critical event (<xref ref-type="bibr" rid="B4">Arthur and Ley, 2013</xref>; <xref ref-type="bibr" rid="B14">Dorrington and Fraser, 2019</xref>; <xref ref-type="bibr" rid="B38">Sharif et al., 2007</xref>). Therefore, these factors were investigated to better understand LMW-C signaling in macrophages and the potential roles of extracellular signal-related kinase 1/2 (ERK 1/2) and c-Jun N-terminal kinase (JNK, the members of the MAPK family), and the NF-&#x3ba;B transcription factor in LMW-C-induced iNOS expression. Using selective inhibitors of JNK (SP600125), ERK1/2 (U0126, which blocks the kinases MEK-1 and MEK-2 that are crucial for the Ras/Raf/MEK/ERK signaling pathway), and NF-&#x3ba;B (JSH23, which blocks the nuclear translocation of the p65 subunit of NF-&#x3ba;B), a significant reduction in NO production in response to LMW-C was observed. The observed effect for LMW was similar to that of the pathway activated by the classic activator, LPS (<xref ref-type="fig" rid="F6">Figure 6</xref>). These findings demonstrate that LMW-C induces iNOS expression in mouse macrophages through positive signaling mediated by the JNK and ERK1/2 MAPK pathways. Additionally, they confirm the involvement of the NF-&#x3ba;B transcription factor in activating the <italic>iNOS</italic> gene.</p>
<fig id="F5" position="float">
<label>FIGURE 5</label>
<caption>
<p>Effect of LMW-C and derivatives <bold>CS-1, 4, 10, 13, 17,</bold> and <bold>18</bold> on nitric oxide production in BMDM cells <bold>(A)</bold>, during inflammation <bold>(B)</bold>, or in a protective model <bold>(C)</bold>. BMDM cells (1 &#xd7; 10<sup>6</sup>/mL) were <bold>(A)</bold> treated with LMW-C or its derivatives at concentrations of 10 and 100 &#x3bc;g/mL or with LPS (1 &#x3bc;g/mL) as a positive control for 24 h; <bold>(B)</bold> pre-incubated for 5 h with LPS, and then LMW-C or its derivatives at concentrations of 10 and 100 &#x3bc;g/mL were added; <bold>(C)</bold> pretreated with LMW-C or its derivatives at 10 and 100 &#x3bc;g/mL concentrations for 5 h and then stimulated with LPS (1 &#x3bc;g/mL) to induce a pro-inflammatory response. After 24 h, cell culture supernatants were collected, and nitric oxide production was assessed by measuring nitrite levels by the Griess reaction. Statistical analysis was performed by one-way ANOVA. Significant differences in NO levels compared to the untreated control <bold>(A, B)</bold> or LPS <bold>(B, C)</bold> were indicated (&#x2a;p &#x2264; 0.05, &#x2a;&#x2a;p &#x2264; 0.001, &#x2a;&#x2a;&#x2a;p &#x2264; 0.0005, and &#x2a;&#x2a;&#x2a;&#x2a;p &#x2264; 0.0001). Data represent the mean &#xb1; SD of three independent experiments (n &#x3d; 3).</p>
</caption>
<graphic xlink:href="fmolb-12-1635564-g005.tif">
<alt-text content-type="machine-generated">Bar charts labeled A, B, and C show nitric oxide (NO) levels in micromolars (uM) for different treatments. The x-axis lists various treatment groups, and the y-axis indicates NO concentration. Labeled lines with asterisks indicate statistical significance between groups. Each chart represents different experimental conditions, highlighting variations in NO levels.</alt-text>
</graphic>
</fig>
<fig id="F6" position="float">
<label>FIGURE 6</label>
<caption>
<p>Impact of MAPK/NF-kB/iNOS inhibitors on NO production in BMDM macrophages. To check the specificity of NO production, BMDM cells (1 &#xd7; 10<sup>6</sup>/mL) were first pretreated for 1 h with selective iNOS inhibitor S-MIU (10 &#xb5;M), ERK 1/2 inhibitor U0126 (20 &#xb5;M), JNK inhibitor SP600125 (10 &#xb5;M), or JSH23 inhibitor (10 &#xb5;M) and then cultured with LMW-C (100 &#x3bc;g/mL) or the positive control LPS (1 &#x3bc;g/mL) for 24 h in 5% CO<sub>2</sub>/95% air. Thereafter, supernatants were collected, and the level of NO was detected by the Griess reaction. The results represent at least three independent experiments (n &#x3d; 3&#x2013;4), and data are presented as the mean &#xb1; SD. One-way ANOVA test was used to examine the differences between LPS or LMW-C-treated cells in the presence or absence of inhibitors (&#x2a;p &#x2264; 0.05, &#x2a;&#x2a;p &#x2264; 0.001, &#x2a;&#x2a;&#x2a;p &#x2264; 0, and &#x2a;&#x2a;&#x2a;&#x2a;p &#x2264; 0.0001).</p>
</caption>
<graphic xlink:href="fmolb-12-1635564-g006.tif">
<alt-text content-type="machine-generated">Bar graph showing nitric oxide (NO) levels in various treatments, measured in micromolar (uM). Control has the lowest NO level, while LPS and LMW treatments have significantly higher levels. Statistical significance is indicated with asterisks, showing differences between treatments. Error bars represent standard deviation.</alt-text>
</graphic>
</fig>
<p>To evaluate the potential anti-inflammatory properties of LMW-C and its derivatives, the compounds were administered to the cells 5 h after lipopolysaccharide (LPS, a strong pro-inflammatory agent) application. The analysis of their ability to suppress LPS-induced inflammation revealed no inhibitory effect for either LMW-C or any of its derivatives (<xref ref-type="fig" rid="F5">Figure 5B</xref>). However, pre-incubation of BMDM cells with the investigated LMW-curdlan derivatives for 5 h before LPS stimulation showed a significant and dose-dependent inhibitory effect. <bold>CS-4, CS-10, CS-13, CS-17,</bold> and <bold>CS-18</bold> derivatives, but not <bold>CS-1</bold>, appeared to be effective in modulating LPS-induced NO production compared to native LMW-curdlan, highlighting their enhanced immunomodulatory potential (<xref ref-type="fig" rid="F5">Figure 5C</xref>). Interestingly, <bold>CS-1</bold> has one of the lowest total DSs (0.70) among the tested sulfated derivatives (see <xref ref-type="table" rid="T1">Tables 1</xref>, <xref ref-type="table" rid="T2">2</xref>; <xref ref-type="fig" rid="F4">Figure 4</xref>); nonetheless, the protective effect against the LPS-induced pro-inflammatory response appears to depend not only on the total amount of sulfate groups on the polysaccharide, as derivative <bold>CS-18</bold> shows a dose-dependent effect in spite of a slightly lower total DS value (0.65). The marked difference in sulfation pattern&#x2014;<bold>CS-1</bold> carries sulfate groups only at the O-6 positions, whereas <bold>CS-18</bold> carries them almost exclusively at the O-2 sites&#x2014;suggests a role of such a structural feature, as is typically the case for the biological activities of GAGs.</p>
<p>The immunomodulatory potential of LMW-C and its derivatives were also determined by assessing their effects on the production of the pro-inflammatory cytokine TNF-&#x3b1;, pleiotropic cytokine IL-6, and the anti-inflammatory cytokine IL-10 in BMDM cells. Treatment with LMW-C or its derivatives at a dose of 100 &#x3bc;g/mL increased pro-inflammatory TNF-&#x3b1; (<xref ref-type="fig" rid="F7">Figure 7A</xref>) and pleiotropic IL-6 (<xref ref-type="fig" rid="F8">Figure 8A</xref>) levels. However, this effect was only statistically significant for LMW-C and <bold>CS-1, 18</bold>. There was no effect on anti-inflammatory IL-10 production (data not presented). Furthermore, pre-incubation of BMDM cells with LPS for 5 hours, followed by treatment with samples (<xref ref-type="fig" rid="F7">Figures 7B</xref>, <xref ref-type="fig" rid="F8">8B</xref>), or pre-incubation of BMDM cells with the tested compounds for 5 hours, followed by treatment with LPS (<xref ref-type="fig" rid="F7">Figures 7C</xref>, <xref ref-type="fig" rid="F8">8C</xref>), showed that neither LMW-C nor its derivatives inhibited LPS-induced TNF-&#x3b1; and IL-6 production. Conversely, 5 hours of pre-incubation with LMW-C, followed by treatment with LPS, increased the IL-6 levels (p &#x2264; 0.0958), suggesting its potential modulatory ability in inflammation.</p>
<fig id="F7" position="float">
<label>FIGURE 7</label>
<caption>
<p>Effect of LMW-C and its derivatives <bold>CS-1, 4, 10, 13, 17,</bold> and <bold>18</bold> on TNF-&#x3b1; production in BMDM cells <bold>(A)</bold>, during inflammation <bold>(B)</bold>, or in a protective model <bold>(C)</bold>. BMDM cells (1 &#xd7; 10<sup>6</sup>/mL) were <bold>(A)</bold> treated with LMW-C or its derivatives at concentrations of 10 and 100 &#x3bc;g/mL or with LPS (1 &#x3bc;g/mL) as a positive control for 24 h; <bold>(B)</bold> pre-incubated for 5 h with LPS, and then LMW-C or its derivatives at concentrations of 10 and 100 &#x3bc;g/mL were added. LPS alone (1 &#x3bc;g/mL) was used as a reference control; <bold>(C)</bold> pretreated with LMW-C or its derivatives at 10 and 100 &#x3bc;g/mL concentrations for 5 h, and then the cells were stimulated with LPS (1 &#x3bc;g/mL) to induce a pro-inflammatory response. After 24 h, cell culture supernatants were collected, and TNF-&#x3b1; level was measured by ELISA. Statistical analysis was performed by one-way ANOVA. Significant differences in TNF-&#x3b1; levels compared to the untreated control <bold>(A, B, C)</bold> or LPS <bold>(B, C)</bold> were indicated (&#x2a;p &#x2264; 0.05, &#x2a;&#x2a;&#x2a;p &#x2264; 0.0005, and &#x2a;&#x2a;&#x2a;&#x2a;p &#x2264; 0.0001). Data represent the mean &#xb1; SD of three independent experiments (n &#x3d; 3&#x2013;4).</p>
</caption>
<graphic xlink:href="fmolb-12-1635564-g007.tif">
<alt-text content-type="machine-generated">Bar graphs labeled A, B, and C show TNF-&#x3B1; levels in nanograms per milliliter under different conditions. Graph A shows significantly higher TNF-&#x3B1; for LPS and LMW-C/10 compared to other samples. Graph B shows relatively consistent TNF-&#x3B1; levels across samples with slight elevation in the control. Graph C shows significant TNF-&#x3B1; reduction for LPS compared to other samples, with consistent levels in others. Asterisks indicate statistical significance.</alt-text>
</graphic>
</fig>
<fig id="F8" position="float">
<label>FIGURE 8</label>
<caption>
<p>Effect of LMW-C and its derivatives <bold>CS-1, 4, 10, 13, 17,</bold> and <bold>18</bold> on IL-6 production in BMDM cells <bold>(A)</bold>, during inflammation <bold>(B)</bold>, or in a protective model <bold>(C)</bold>. BMDM cells (1 &#xd7; 10<sup>6</sup>/mL) were <bold>(A)</bold> treated with LMW-C or its derivatives at concentrations of 10 and 100 &#x3bc;g/mL or with LPS (1 &#x3bc;g/mL) as a positive control for 24 h; <bold>(B)</bold> pre-incubated for 5 h with LPS, and then LMW-C or its derivatives at concentrations of 10 and 100 &#x3bc;g/mL were added. LPS alone (1 &#x3bc;g/mL) was used as a reference control; <bold>(C)</bold> pretreated with LMW-C or its derivatives at 10 and 100 &#x3bc;g/mL concentrations for 5 h, and then the cells were stimulated with LPS (1 &#x3bc;g/mL) to induce a pro-inflammatory response. After 24 h, cell culture supernatants were collected, and IL-6 level was measured by ELISA. Statistical analysis was performed by one-way ANOVA. Significant differences in TNF-&#x3b1; levels compared to the untreated control <bold>(A, B, C)</bold> or LPS <bold>(B, C)</bold> were indicated (&#x2a;p &#x2264; 0.05, &#x2a;&#x2a;p &#x2264; 0.001, &#x2a;&#x2a;&#x2a;p &#x2264; 0.0005, and &#x2a;&#x2a;&#x2a;&#x2a;p &#x2264; 0.0001). Data represent the mean &#xb1; SD of at least three independent experiments (n &#x3d; 3&#x2013;7).</p>
</caption>
<graphic xlink:href="fmolb-12-1635564-g008.tif">
<alt-text content-type="machine-generated">Bar graphs labeled A, B, and C show IL-6 levels in pg/ml under various conditions. Graph A shows significant differences in IL-6 levels between control, LPS, LMWC/10, and others. Graph B displays IL-6 levels with similar significant differences for LPS and other treatments. Graph C depicts IL-6 levels after five-hour preincubation, showing variances among conditions, notably for LMWC/100. Bars indicate variation with some labeled significance levels.</alt-text>
</graphic>
</fig>
<p>The expression and production of TNF-&#x3b1; and IL-6 are triggered by mitogen-activated protein kinase (MAPK) pathways, particularly the ERK and JNK pathways, and by the activation of the NF-&#x3ba;B factor, which is similar to the process of NO production (<xref ref-type="bibr" rid="B4">Arthur and Ley, 2013</xref>; <xref ref-type="bibr" rid="B29">Lawrence, 2009</xref>). Using selective inhibitors of the MAPK&#x2013;NF-&#x3ba;B signaling pathways in our study confirmed the involvement of ERK1/2 and JNK kinases in regulating TNF-&#x3b1; (<xref ref-type="fig" rid="F9">Figure 9B</xref>) and IL-6 (<xref ref-type="fig" rid="F10">Figure 10B</xref>) expression in BMDM cells stimulated with LMW-C, and derivatives <bold>CS-1, 18</bold>, which is comparable to control activator LPS (<xref ref-type="fig" rid="F9">Figures 9A</xref>, <xref ref-type="fig" rid="F10">10A</xref>). We also demonstrated the significant role of the transcription factor NF-&#x3ba;B in the signaling pathway activated by LMW-C and the <bold>CS-18</bold> derivative. Interestingly, the <bold>CS-1</bold> derivative showed a substantial decrease in IL-6 and TNF-&#x3b1; production when combined with NF-&#x3ba;B inhibitor JSH-23 (<xref ref-type="fig" rid="F9">Figures 9B</xref>, <xref ref-type="fig" rid="F10">10B</xref>). However, this reduction was not statistically significant. This suggests the potential involvement of additional transcription factors, such as AP-1, or alternative signaling pathways that compensate for NF-&#x3ba;B inhibition.</p>
<fig id="F9" position="float">
<label>FIGURE 9</label>
<caption>
<p>Impact of MAPK/NF-&#x3ba;B/iNOS inhibitors on TNF-&#x3b1; production in BMDM macrophages. To check the specificity of TNF-&#x3b1; production, BMDM cells (1 &#xd7; 10<sup>6</sup>/mL) were first pretreated for 1 h with selective iNOS inhibitor S-MIU (10 &#xb5;M), ERK 1/2 inhibitor U0126 (20 &#xb5;M), JNK inhibitor SP600125 (10 &#xb5;M), or JSH23 inhibitor (10 &#xb5;M) and then cultured with positive control LPS (1 &#x3bc;g/mL) <bold>(A)</bold> or LMW-C, <bold>CS-1,</bold> and <bold>CS-18</bold> (100 &#x3bc;g/mL) <bold>(B)</bold> for 24 h in 5% CO<sub>2</sub>/95% air. Thereafter, supernatants were collected, and the level of TNF-&#x3b1; was detected by ELISA. The results represent at least two independent experiments (n &#x3d; 2&#x2013;4), and data are presented as the mean &#xb1; SD. One-way ANOVA test was used to examine the differences between LPS or LMW-C-treated cells in the presence or absence of inhibitors (&#x2a;&#x2a;p &#x2264; 0.001, &#x2a;&#x2a;&#x2a;p &#x2264; 0.001, and &#x2a;&#x2a;&#x2a;&#x2a;p &#x2264; 0.0001).</p>
</caption>
<graphic xlink:href="fmolb-12-1635564-g009.tif">
<alt-text content-type="machine-generated">Bar graphs labeled A and B display TNF-alpha levels in nanograms per milliliter. Graph A shows an increase with LPS and reductions with U0126/LPS, SP600125/LPS, and JSH23/LPS treatments. Graph B shows various treatments, with CS.18 combined treatments showing reduced levels. Statistical significance is indicated by asterisks above bars.</alt-text>
</graphic>
</fig>
<fig id="F10" position="float">
<label>FIGURE 10</label>
<caption>
<p>Impact of MAPK/NF-&#x3ba;B/iNOS inhibitors on IL-6 production in BMDM macrophages. To check the specificity of IL-6 production, BMDM cells (1 &#xd7; 10<sup>6</sup>/mL) were first pretreated for 1 h with selective iNOS inhibitor S-MIU (10 &#xb5;M), ERK 1/2 inhibitor U0126 (20 &#xb5;M), JNK inhibitor SP600125 (10 &#xb5;M), or JSH23 inhibitor (10 &#xb5;M) and then cultured with positive control LPS (1 &#x3bc;g/mL) <bold>(A)</bold> or LMW-C, <bold>CS-1,</bold> and <bold>CS-18</bold> (100 &#x3bc;g/mL) <bold>(B)</bold> for 24 h in 5% CO<sub>2</sub>/95% air. Thereafter, supernatants were collected, and the level of IL-6 was detected by ELISA. The results represent at least two independent experiments (n &#x3d; 2&#x2013;4), and data are presented as the mean &#xb1; SD. One-way ANOVA test was used to examine the differences between LPS or LMW-C-treated cells in the presence or absence of inhibitors (&#x2a;p &#x2264; 0.05, &#x2a;&#x2a;p &#x2264; 0.001, &#x2a;&#x2a;&#x2a;p &#x2264; 0, and &#x2a;&#x2a;&#x2a;&#x2a;p &#x2264; 0.0001).</p>
</caption>
<graphic xlink:href="fmolb-12-1635564-g010.tif">
<alt-text content-type="machine-generated">Bar graphs A and B depict IL-6 levels in pg/ml for different treatments. Graph A shows higher IL-6 levels for LPS compared to control, with significant reductions when treated with U0126, SP600125, and JSH23. Graph B shows elevated IL-6 levels for LMW-C and CS-1 treatments compared to control, with significant decreases when combined with U0126, SP600125, and JSH23. Statistical significance is indicated by stars.</alt-text>
</graphic>
</fig>
<p>To investigate the role of sulfation in derivatives <bold>CS-1, 4, 10, 13, 17,</bold> and <bold>18</bold> on the activity of TLR receptors, we examined HEK-Blue&#x2122; cells stably transfected with hTLR2 or hTLR4. All the tested samples activated TLR2, and we did not observe any significant difference among sulfated derivatives when compared to LMW-C (<xref ref-type="fig" rid="F11">Figure 11A</xref>). However, we observed that activation of the TLR4 receptor varied among curdlan sulfate products, as two of them (<bold>CS-1</bold> and <bold>CS-17)</bold> did not induce TLR4 activation (<xref ref-type="fig" rid="F11">Figure 11B</xref>). Interestingly, this effect could not be simply ascribed to the amount of sulfate groups on the polysaccharide backbone as <bold>CS-1</bold> and <bold>CS-17</bold> showed neither the lowest nor the highest total DS values among the tested derivatives (<xref ref-type="table" rid="T1">Tables 1</xref>, <xref ref-type="table" rid="T2">2</xref>; <xref ref-type="fig" rid="F4">Figure 4</xref>). Subtler structural features could be involved; however, they cannot be unveiled at the current state of the art.</p>
<fig id="F11" position="float">
<label>FIGURE 11</label>
<caption>
<p>Recognition of native LMW-C and <bold>CS-1, 4, 10, 13, 17,</bold> and <bold>18</bold> derivatives by innate immune receptors. HEK Blue&#x2122; cells were seeded on the plate and stimulated with samples (10 &#x3bc;g/mL). The positive control for TLR2 recognition was PAMP <bold>(A)</bold>, whereas LPS was used as the positive control for TLR4 cells <bold>(B)</bold>. The data represent three independent experiments. One-way ANOVA with Dunnett&#x2019;s multiple comparison test was used to compare treated cells with non-treated control (medium) and the <bold>CS-1, 4, 10, 13, 17,</bold> and <bold>18</bold> derivatives with LMW-C. &#x2a;<italic>p</italic> &#x2264; 0.05, &#x2a;&#x2a;<italic>p</italic> &#x2264; 0.01, and ns&#x2013;not significant.</p>
</caption>
<graphic xlink:href="fmolb-12-1635564-g011.tif">
<alt-text content-type="machine-generated">Bar charts labeled A and B show absorbance at 610 nanometers for HEK-Blue&#x2122; hTLR2 and hTLR4 assays, respectively. Chart A shows higher absorbance for PAMP10, with no significant differences (ns) among other samples. Chart B indicates significant differences, with LPS1 showing the highest absorbance, and asterisks denote statistical significance between certain groups.</alt-text>
</graphic>
</fig>
<p>The induction of IL-6, TNF-&#x3b1;, and NO indicates the activation of classical inflammatory pathways and suggests the involvement of TLRs (<xref ref-type="bibr" rid="B1">Aizawa et al., 2018</xref>; <xref ref-type="bibr" rid="B32">Liu et al., 2019</xref>). Therefore, it is plausible that LMW-curdlan and its derivatives <bold>CS-1</bold> and <bold>CS-18</bold> activate TLRs, which is consistent with literature reports describing polysaccharides as ligands for pattern recognition receptors (PRRs) (<xref ref-type="bibr" rid="B28">Kanjan et al., 2017</xref>; <xref ref-type="bibr" rid="B30">Li et al., 2022</xref>; <xref ref-type="bibr" rid="B40">Stothers et al., 2021</xref>). However, the absence of an immunostimulatory effect observed with the other LMW-C derivatives may suggest an altered affinity for TLR2 or TLR4 receptors. This could be because of chemical modifications that change the molecule&#x2019;s conformation, thereby preventing receptor activation. When analyzing interactions with LPS, a potent TLR4 agonist, the co-stimulation test can be used to assess the effect of LMW-C and its derivatives on the activation of TLR4-mediated inflammatory pathways. The lack of inhibitory activity observed when LPS and the tested compounds were administered simultaneously may result from receptor competition or the short duration of action of these substances.</p>
<p>During the initial 5-h incubation period, LMW-C and its derivatives significantly reduced the NO levels in a dose-dependent manner. In contrast, unmodified LMW-C significantly increased the IL-6 levels. This may indicate an early form of cell &#x201c;conditioning,&#x201d; possibly through the modulation of TLR2 or TLR4 expression. Overall, these results suggest that the immunological activity of macrophages is significantly impacted by chemical modifications to LMW-C, and that its derivatives may exert immunomodulatory effects, particularly following prior exposure. This effect could help in preventing excessive TLR4 activation by LPS, highlighting the potential of these substances as candidates for modulating the inflammatory response.</p>
<p>However, this study also has certain limitations. First, there is a need to conduct direct investigations of TLR2 and TLR4 activation, such as studies using knockout cell lines or reporter assays. It is also important to include the analysis of the dectin-1 receptor, as it can induce inflammatory responses in macrophages both independently and in cooperation with TLR2 and/or 4. The presented analysis of signaling pathways regulating NO and cytokine production, based on the use of selective inhibitors of MAP kinases, NF-&#x3ba;B, and iNOS, requires further validation through gene expression studies or assessment of protein phosphorylation levels using techniques such as Western blotting. This work is planned for the near future and will be published elsewhere.</p>
</sec>
</sec>
<sec sec-type="conclusion" id="s4">
<title>4 Conclusion</title>
<p>A comprehensive study of the regioselective sulfation of LMW-C was accomplished in this work by means of three complementary semi-synthetic strategies based on (i) direct, mild sulfation reactions of only the most reactive hydroxyls, (ii) desulfation of the most reactive sulfate groups of a persulfated LMW-C derivative, or (iii) multistep methods relying on the regioselective installation of trityl ether or benzoyl ester protecting groups at the less hindered sites, followed by sulfation and deprotection. The three approaches produced a set of 12 curdlan sulfate derivatives, which were characterized in terms of total DS and sulfation pattern (DS-2, DS-4, and DS-6) by means of <sup>1</sup>H- and 2D-NMR techniques. They complemented the six semi-synthetic derivatives that were already reported by us (<xref ref-type="bibr" rid="B41">Vessella et al., 2021a</xref>) to give a significantly broad coverage of the theoretically possible structural features. Indeed, among the semi-synthesized derivatives, the total DS value spanned from 0.34 to 3.00, whereas DS-2, DS-4, and DS-6 all ranged from 0 to 1. Six derivatives were selected from the set as representatives of such broadly variable structural features and then subjected to a preliminary screening of their immunomodulatory effects on pro-inflammatory TNF-&#x3b1;, pleiotropic IL-6, anti-inflammatory IL-10, and NO production by BMDM cells in comparison with the starting LMW-C polysaccharide. Some differences were detected not only between LMW-C and its sulfated derivatives but also among the set of tested curdlan sulfate products. This could suggest a role of the sulfation degree and sulfation pattern in the immunomodulant activity, which will be investigated further in the near future by additional immunological studies and molecular docking investigation of the TLR2 and TLR4 binding mode of the sulfated LMW-C derivatives.</p>
</sec>
</body>
<back>
<sec sec-type="data-availability" id="s5">
<title>Data availability statement</title>
<p>The original contributions presented in the study are included in the article/<xref ref-type="sec" rid="s11">Supplementary Material</xref>; further inquiries can be directed to the corresponding author.</p>
</sec>
<sec sec-type="author-contributions" id="s6">
<title>Author contributions</title>
<p>FE: conceptualization, methodology, investigation, writing &#x2013; review and editing, resources. AZ: investigation, methodology, and writing &#x2013; original draft. ST: conceptualization writing &#x2013; review and editing. AI: writing &#x2013; review and editing conceptualization. SG: conceptualization, writing &#x2013; review and editing, and methodology. EB: funding acquisition, project administration, writing &#x2013; original draft, conceptualization, methodology.</p>
</sec>
<sec sec-type="funding-information" id="s7">
<title>Funding</title>
<p>The author(s) declare that financial support was received for the research and/or publication of this article. EB thanks the Italian Ministry of Enterprises and Made in Italy (MIMIT, CROSSGAG project, CUP: B69J24001940005) and the Italian Ministry of University and Research (MUR, HealHyal project, CUP: E53D23020320001) for funding.</p>
</sec>
<sec sec-type="COI-statement" id="s8">
<title>Conflict of interest</title>
<p>The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.</p>
</sec>
<sec sec-type="ai-statement" id="s9">
<title>Generative AI statement</title>
<p>The author(s) declare that no Generative AI was used in the creation of this manuscript.</p>
</sec>
<sec sec-type="disclaimer" id="s10">
<title>Publisher&#x2019;s note</title>
<p>All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.</p>
</sec>
<sec sec-type="supplementary-material" id="s11">
<title>Supplementary material</title>
<p>The Supplementary Material for this article can be found online at: <ext-link ext-link-type="uri" xlink:href="https://www.frontiersin.org/articles/10.3389/fmolb.2025.1635564/full#supplementary-material">https://www.frontiersin.org/articles/10.3389/fmolb.2025.1635564/full&#x23;supplementary-material</ext-link>
</p>
<supplementary-material xlink:href="Supplementaryfile1.docx" id="SM1" mimetype="application/docx" xmlns:xlink="http://www.w3.org/1999/xlink"/>
</sec>
<ref-list>
<title>References</title>
<ref id="B1">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Aizawa</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Watanabe</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Tominari</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Matsumoto</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Hirata</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Grundler</surname>
<given-names>F. M. W.</given-names>
</name>
<etal/>
</person-group> (<year>2018</year>). <article-title>Low molecular-weight curdlan, (1&#x2192;3)-&#x3b2;-glucan suppresses TLR2-induced RANKL-dependent bone resorption</article-title>. <source>Biol. Pharm. Bull.</source> <volume>41</volume>, <fpage>1282</fpage>&#x2013;<lpage>1285</lpage>. <pub-id pub-id-type="doi">10.1248/bpb.b18-00057</pub-id>
<pub-id pub-id-type="pmid">30068878</pub-id>
</citation>
</ref>
<ref id="B2">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Arango Duque</surname>
<given-names>G.</given-names>
</name>
<name>
<surname>Descoteaux</surname>
<given-names>A.</given-names>
</name>
</person-group> (<year>2014</year>). <article-title>Macrophage cytokines: involvement in immunity and infectious diseases</article-title>. <source>Front. Immunol.</source> <volume>5</volume>, <fpage>491</fpage>. <pub-id pub-id-type="doi">10.3389/fimmu.2014.00491</pub-id>
<pub-id pub-id-type="pmid">25339958</pub-id>
</citation>
</ref>
<ref id="B3">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Arlov</surname>
<given-names>&#xd8;.</given-names>
</name>
<name>
<surname>R&#xfc;tsche</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>Korayem</surname>
<given-names>M. A.</given-names>
</name>
<name>
<surname>&#xd6;zt&#xfc;rk</surname>
<given-names>E.</given-names>
</name>
<name>
<surname>Zenobi-Wong</surname>
<given-names>M.</given-names>
</name>
</person-group> (<year>2021</year>). <article-title>Engineered sulfated polysaccharides for biomedical applications</article-title>. <source>Adv. Funct. Mat.</source> <volume>31</volume>, <fpage>2010732</fpage>. <pub-id pub-id-type="doi">10.1002/adfm.202010732</pub-id>
</citation>
</ref>
<ref id="B4">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Arthur</surname>
<given-names>J. S. C.</given-names>
</name>
<name>
<surname>Ley</surname>
<given-names>S. V.</given-names>
</name>
</person-group> (<year>2013</year>). <article-title>Mitogen-activated protein kinases in innate immunity</article-title>. <source>Nat. Rev. Immunol.</source> <volume>13</volume>, <fpage>679</fpage>&#x2013;<lpage>692</lpage>. <pub-id pub-id-type="doi">10.1038/nri3495</pub-id>
<pub-id pub-id-type="pmid">23954936</pub-id>
</citation>
</ref>
<ref id="B5">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Bedini</surname>
<given-names>E.</given-names>
</name>
<name>
<surname>Cassese</surname>
<given-names>E.</given-names>
</name>
<name>
<surname>D&#x2019;Agostino</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Cammarota</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Frezza</surname>
<given-names>M. A.</given-names>
</name>
<name>
<surname>Lepore</surname>
<given-names>M.</given-names>
</name>
<etal/>
</person-group> (<year>2023</year>). <article-title>Self-esterified hyaluronan hydrogels: advancements in the production with positive implications in tissue healing</article-title>. <source>Int. J. Biol. Macromol.</source> <volume>236</volume>, <fpage>123873</fpage>. <pub-id pub-id-type="doi">10.1016/j.ijbiomac.2023.123873</pub-id>
<pub-id pub-id-type="pmid">36870627</pub-id>
</citation>
</ref>
<ref id="B6">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Bedini</surname>
<given-names>E.</given-names>
</name>
<name>
<surname>Laezza</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Parrilli</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Iadonisi</surname>
<given-names>A.</given-names>
</name>
</person-group> (<year>2017</year>). <article-title>A review of chemical methods for the selective sulfation and desulfation of polysaccharides</article-title>. <source>Carbohydr. Polym.</source> <volume>174</volume>, <fpage>1224</fpage>&#x2013;<lpage>1239</lpage>. <pub-id pub-id-type="doi">10.1016/j.carbpol.2017.07.017</pub-id>
<pub-id pub-id-type="pmid">28821048</pub-id>
</citation>
</ref>
<ref id="B7">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Caputo</surname>
<given-names>H. E.</given-names>
</name>
<name>
<surname>Straub</surname>
<given-names>J. E.</given-names>
</name>
<name>
<surname>Grinstaff</surname>
<given-names>M.</given-names>
</name>
</person-group> (<year>2019</year>). <article-title>Design, synthesis, and biomedical applications of synthetic sulphated polysaccharides</article-title>. <source>Chem. Soc. Rev.</source> <volume>48</volume>, <fpage>2338</fpage>&#x2013;<lpage>2365</lpage>. <pub-id pub-id-type="doi">10.1039/C7CS00593H</pub-id>
<pub-id pub-id-type="pmid">30742140</pub-id>
</citation>
</ref>
<ref id="B8">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Chaidedgumjorn</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Toyoda</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Woo</surname>
<given-names>E. R.</given-names>
</name>
<name>
<surname>Lee</surname>
<given-names>K. B.</given-names>
</name>
<name>
<surname>Kim</surname>
<given-names>Y. S.</given-names>
</name>
<name>
<surname>Toida</surname>
<given-names>T.</given-names>
</name>
<etal/>
</person-group> (<year>2002</year>). <article-title>Effect of (1 &#x2192; 3)- and (1 &#x2192; 4)-linkages of fully sulfated polysaccharides on their anticoagulant activity</article-title>. <source>Carbohydr. Res.</source> <volume>337</volume>, <fpage>925</fpage>&#x2013;<lpage>933</lpage>. <pub-id pub-id-type="doi">10.1016/S0008-6215(02)00078-2</pub-id>
<pub-id pub-id-type="pmid">12007475</pub-id>
</citation>
</ref>
<ref id="B9">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Chaudhari</surname>
<given-names>V.</given-names>
</name>
<name>
<surname>Singht Buttar</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Bagwe-Parab</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Singh Tuli</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Vora</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Kaur</surname>
<given-names>G.</given-names>
</name>
</person-group> (<year>2021</year>). <article-title>Therapeutic and industrial applications of curdlan with overview on its recent patents</article-title>. <source>Front. Nutr.</source> <volume>8</volume>, <fpage>646988</fpage>. <pub-id pub-id-type="doi">10.3389/fnut.2021.646988</pub-id>
<pub-id pub-id-type="pmid">34262922</pub-id>
</citation>
</ref>
<ref id="B10">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Chen</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Deng</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Cui</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Fang</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Zuo</surname>
<given-names>Z.</given-names>
</name>
<name>
<surname>Deng</surname>
<given-names>J.</given-names>
</name>
<etal/>
</person-group> (<year>2018</year>). <article-title>Inflammatory responses and inflammation-associated diseases in organs</article-title>. <source>Oncotarget</source> <volume>9</volume>, <fpage>7204</fpage>&#x2013;<lpage>7218</lpage>. <pub-id pub-id-type="doi">10.18632/oncotarget.23208</pub-id>
<pub-id pub-id-type="pmid">29467962</pub-id>
</citation>
</ref>
<ref id="B11">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Chen</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>F.</given-names>
</name>
</person-group> (<year>2020</year>). <article-title>Review on the preparation, biological activities and applications of curdlan and its derivatives</article-title>. <source>Eur. Polym. J.</source> <volume>141</volume>, <fpage>110096</fpage>. <pub-id pub-id-type="doi">10.1016/j.eurpolymj.2020.110096</pub-id>
</citation>
</ref>
<ref id="B12">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Chien</surname>
<given-names>C.-Y.</given-names>
</name>
<name>
<surname>Enomoto-Rogers</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Takemura</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Iwata</surname>
<given-names>T.</given-names>
</name>
</person-group> (<year>2017</year>). <article-title>Synthesis and characterization of regioselectively substituted curdlan hetero esters via an unexpected acyl migration</article-title>. <source>Carbohydr. Polym.</source> <volume>155</volume>, <fpage>440</fpage>&#x2013;<lpage>447</lpage>. <pub-id pub-id-type="doi">10.1016/j.carbpol.2016.08.067</pub-id>
<pub-id pub-id-type="pmid">27702533</pub-id>
</citation>
</ref>
<ref id="B13">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Chien</surname>
<given-names>C.-Y.</given-names>
</name>
<name>
<surname>Iwata</surname>
<given-names>T.</given-names>
</name>
</person-group> (<year>2018</year>). <article-title>Synthesis and characterization of regioselectively substituted curdlan hetero esters with different ester groups on primary and secondary hydroxyl groups</article-title>. <source>Carbohydr. Polym.</source> <volume>181</volume>, <fpage>300</fpage>&#x2013;<lpage>306</lpage>. <pub-id pub-id-type="doi">10.1016/j.carbpol.2017.10.046</pub-id>
<pub-id pub-id-type="pmid">29253976</pub-id>
</citation>
</ref>
<ref id="B14">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Dorrington</surname>
<given-names>M. G.</given-names>
</name>
<name>
<surname>Fraser</surname>
<given-names>I. D. C.</given-names>
</name>
</person-group> (<year>2019</year>). <article-title>NF-&#x3ba;B signaling in macrophages: dynamics, crosstalk, and signal integration</article-title>. <source>Front. Immunol.</source> <volume>10</volume>, <fpage>705</fpage>. <pub-id pub-id-type="doi">10.3389/fimmu.2019.00705</pub-id>
<pub-id pub-id-type="pmid">31024544</pub-id>
</citation>
</ref>
<ref id="B15">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Esposito</surname>
<given-names>F.</given-names>
</name>
<name>
<surname>Vessella</surname>
<given-names>G.</given-names>
</name>
<name>
<surname>Sinquin</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Traboni</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Iadonisi</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Colliec-Jouault</surname>
<given-names>S.</given-names>
</name>
<etal/>
</person-group> (<year>2022</year>). <article-title>Glycosaminoglycan-like sulfated polysaccharides from <italic>Vibrio diabolicus</italic> bacterium: semi-synthesis and characterization</article-title>. <source>Carbohydr. Polym.</source> <volume>283</volume>, <fpage>119054</fpage>. <pub-id pub-id-type="doi">10.1016/j.carbpol.2021.119054</pub-id>
<pub-id pub-id-type="pmid">35153009</pub-id>
</citation>
</ref>
<ref id="B16">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Farahani</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Farahani</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Kashfi</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Ghasemi</surname>
<given-names>A.</given-names>
</name>
</person-group> (<year>2025</year>). <article-title>Inducible nitric oxide synthase (iNOS): more than an inducible enzyme? Rethinking the classification of NOS isoforms</article-title>. <source>Pharmacol. Res.</source> <volume>216</volume>, <fpage>107781</fpage>. <pub-id pub-id-type="doi">10.1016/j.phrs.2025.107781</pub-id>
<pub-id pub-id-type="pmid">40389042</pub-id>
</citation>
</ref>
<ref id="B17">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Fonseca</surname>
<given-names>R. J. C.</given-names>
</name>
<name>
<surname>Oliveira</surname>
<given-names>S.-N. M. C. G.</given-names>
</name>
<name>
<surname>Pomin</surname>
<given-names>V. H.</given-names>
</name>
<name>
<surname>Mecawi</surname>
<given-names>A. S.</given-names>
</name>
<name>
<surname>Araujo</surname>
<given-names>I. G.</given-names>
</name>
<name>
<surname>Mour&#xe3;o</surname>
<given-names>P. A. S.</given-names>
</name>
</person-group> (<year>2010</year>). <article-title>Effects of oversulfated and fucosylated chondroitin sulfates on coagulation</article-title>. <source>Thromb. Haemost.</source> <volume>103</volume>, <fpage>994</fpage>&#x2013;<lpage>1004</lpage>. <pub-id pub-id-type="doi">10.1160/TH09-10-0734</pub-id>
<pub-id pub-id-type="pmid">20352164</pub-id>
</citation>
</ref>
<ref id="B18">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Futatsuyama</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Ogawa</surname>
<given-names>K.</given-names>
</name>
</person-group> (<year>1999</year>). <article-title>Viscosimetry of curdlan, a linear (1&#x2192;3)-&#x3b2;-D-glucan, in DMSO or alkaline solutions</article-title>. <source>Biosci. Biotechnol. Biochem.</source> <volume>63</volume>, <fpage>1481</fpage>&#x2013;<lpage>1483</lpage>. <pub-id pub-id-type="doi">10.1271/bbb.63.1481</pub-id>
<pub-id pub-id-type="pmid">27389511</pub-id>
</citation>
</ref>
<ref id="B19">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ganie</surname>
<given-names>S. A.</given-names>
</name>
<name>
<surname>Rather</surname>
<given-names>L. J.</given-names>
</name>
<name>
<surname>Li</surname>
<given-names>Q.</given-names>
</name>
</person-group> (<year>2022</year>). <article-title>Review on anti-cancer and anti-microbial applications of curdlan biomaterials</article-title>. <source>J. Polym. Environ.</source> <volume>30</volume>, <fpage>1284</fpage>&#x2013;<lpage>1299</lpage>. <pub-id pub-id-type="doi">10.1007/s10924-021-02299-9</pub-id>
</citation>
</ref>
<ref id="B20">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Gao</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Fukuda</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Katsuraya</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Kaneko</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Mimura</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Nakashima</surname>
<given-names>H.</given-names>
</name>
<etal/>
</person-group> (<year>1997</year>). <article-title>Synthesis of regioselective substituted curdlan sulfates with medium molecular weights and their specific anti-HIV-1 activities</article-title>. <source>Macromolecules</source> <volume>30</volume>, <fpage>3224</fpage>&#x2013;<lpage>3228</lpage>. <pub-id pub-id-type="doi">10.1021/ma961711d</pub-id>
</citation>
</ref>
<ref id="B21">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Gargiulo</surname>
<given-names>V.</given-names>
</name>
<name>
<surname>Lanzetta</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Parrilli</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>De Castro</surname>
<given-names>C.</given-names>
</name>
</person-group> (<year>2009</year>). <article-title>Structural analysis of chondroitin sulfate from <italic>Scyliorhinus canicula</italic>: a useful source of this polysaccharide</article-title>. <source>Glycobiology</source> <volume>19</volume>, <fpage>1485</fpage>&#x2013;<lpage>1491</lpage>. <pub-id pub-id-type="doi">10.1093/glycob/cwp123</pub-id>
<pub-id pub-id-type="pmid">19696233</pub-id>
</citation>
</ref>
<ref id="B22">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Goodridge</surname>
<given-names>H. S.</given-names>
</name>
<name>
<surname>Wolf</surname>
<given-names>A. J.</given-names>
</name>
<name>
<surname>Underhill</surname>
<given-names>D. M.</given-names>
</name>
</person-group> (<year>2009</year>). <article-title>&#x3b2;-Glucan recognition by the innate immune system</article-title>. <source>Immunol. Rev.</source> <volume>230</volume>, <fpage>38</fpage>&#x2013;<lpage>50</lpage>. <pub-id pub-id-type="doi">10.1111/j.1600-065X.2009.00793.x</pub-id>
<pub-id pub-id-type="pmid">19594628</pub-id>
</citation>
</ref>
<ref id="B23">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Grandpierre</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Janssen</surname>
<given-names>H.-G.</given-names>
</name>
<name>
<surname>Laroche</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Michaud</surname>
<given-names>P.</given-names>
</name>
<name>
<surname>Warrand</surname>
<given-names>J.</given-names>
</name>
</person-group> (<year>2008</year>). <article-title>Enzymatic and chemical degradation of curdlan targeting the production of &#x3b2;-(1&#x2192;3) oligoglucans</article-title>. <source>Carbohydr. Polym.</source> <volume>71</volume>, <fpage>277</fpage>&#x2013;<lpage>286</lpage>. <pub-id pub-id-type="doi">10.1016/j.carbpol.2007.05.042</pub-id>
</citation>
</ref>
<ref id="B24">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Guerrini</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Naggi</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Guglieri</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Santarsiero</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Torri</surname>
<given-names>G.</given-names>
</name>
</person-group> (<year>2005</year>). <article-title>Complex glycosaminoglycans: profiling substitution patterns by two-dimensional nuclear magnetic resonance spectroscopy</article-title>. <source>Anal. Biochem.</source> <volume>337</volume>, <fpage>35</fpage>&#x2013;<lpage>47</lpage>. <pub-id pub-id-type="doi">10.1016/j.ab.2004.10.012</pub-id>
<pub-id pub-id-type="pmid">15649373</pub-id>
</citation>
</ref>
<ref id="B25">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Guevara</surname>
<given-names>I.</given-names>
</name>
<name>
<surname>Iwanejko</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Dembi&#x144;ska-Kie&#x107;</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Pankiewicz</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Wanat</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Anna</surname>
<given-names>P.</given-names>
</name>
<etal/>
</person-group> (<year>1998</year>). <article-title>Determination of nitrite/nitrate in human biological material by the simple Griess reaction</article-title>. <source>Clin. Chim. Acta</source> <volume>274</volume>, <fpage>177</fpage>&#x2013;<lpage>188</lpage>. <pub-id pub-id-type="doi">10.1016/S0009-8981(98)00060-6</pub-id>
<pub-id pub-id-type="pmid">9694586</pub-id>
</citation>
</ref>
<ref id="B26">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Jin</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Mu</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Zhang</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Li</surname>
<given-names>P.</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>F.</given-names>
</name>
</person-group> (<year>2020</year>). <article-title>Preparation and evaluation of the adjuvant effect of curdlan sulfate in improving the efficacy of dendritic cell-based vaccine for antitumor immunotherapy</article-title>. <source>Int. J. Biol. Macromol.</source> <volume>146</volume>, <fpage>273</fpage>&#x2013;<lpage>284</lpage>. <pub-id pub-id-type="doi">10.1016/j.ijbiomac.2019.12.256</pub-id>
<pub-id pub-id-type="pmid">31904453</pub-id>
</citation>
</ref>
<ref id="B27">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kalyanasundaram</surname>
<given-names>G. T.</given-names>
</name>
<name>
<surname>Doble</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Gummadi</surname>
<given-names>S. N.</given-names>
</name>
</person-group> (<year>2012</year>). <article-title>Production and downstream processing of (1&#x2192;3)-&#x3b2;-D-glucan from mutant strain of <italic>Agrobacterium</italic> sp. ATCC 31750</article-title>. <source>AMB Express</source> <volume>2</volume>, <fpage>31</fpage>. <pub-id pub-id-type="doi">10.1186/2191-0855-2-31</pub-id>
<pub-id pub-id-type="pmid">22681895</pub-id>
</citation>
</ref>
<ref id="B28">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kanjan</surname>
<given-names>P.</given-names>
</name>
<name>
<surname>Sahasrabudhe</surname>
<given-names>N. M.</given-names>
</name>
<name>
<surname>de Haan</surname>
<given-names>B. J.</given-names>
</name>
<name>
<surname>de Vos</surname>
<given-names>P.</given-names>
</name>
</person-group> (<year>2017</year>). <article-title>Immune effects of &#x3b2;-glucan are determined by combined effects on Dectin-1, TLR2, 4 and 5</article-title>. <source>J. Funct. Foods</source> <volume>37</volume>, <fpage>433</fpage>&#x2013;<lpage>440</lpage>. <pub-id pub-id-type="doi">10.1016/j.jff.2017.07.061</pub-id>
</citation>
</ref>
<ref id="B29">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Lawrence</surname>
<given-names>T.</given-names>
</name>
</person-group> (<year>2009</year>). <article-title>The nuclear factor NF-&#x3ba;B pathway in inflammation</article-title>. <source>Cold Spring Harb. Perspect. Biol.</source> <volume>1</volume>, <fpage>a001651</fpage>. <pub-id pub-id-type="doi">10.1101/cshperspect.a001651</pub-id>
<pub-id pub-id-type="pmid">20457564</pub-id>
</citation>
</ref>
<ref id="B30">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Li</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Wen</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Huang</surname>
<given-names>X.</given-names>
</name>
<name>
<surname>Nie</surname>
<given-names>Q.</given-names>
</name>
<name>
<surname>Wu</surname>
<given-names>X.</given-names>
</name>
<name>
<surname>Ma</surname>
<given-names>W.</given-names>
</name>
<etal/>
</person-group> (<year>2022</year>). <article-title>Interaction between polysaccharides and toll-like receptor 4: primary structural role, immune balance perspective, and 3D interaction model hypothesis</article-title>. <source>Food Chem.</source> <volume>374</volume>, <fpage>131586</fpage>. <pub-id pub-id-type="doi">10.1016/j.foodchem.2021.131586</pub-id>
<pub-id pub-id-type="pmid">34839969</pub-id>
</citation>
</ref>
<ref id="B31">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Li</surname>
<given-names>P.</given-names>
</name>
<name>
<surname>Tan</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Xu</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>Yin</surname>
<given-names>F.</given-names>
</name>
<name>
<surname>Cheng</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Zhang</surname>
<given-names>X.</given-names>
</name>
<etal/>
</person-group> (<year>2014</year>). <article-title>Effect and mechanisms of curdlan sulfate on inhibiting HBV infection and acting as an HB vaccine adjuvant</article-title>. <source>Carbohydr. Polym.</source> <volume>110</volume>, <fpage>446</fpage>&#x2013;<lpage>455</lpage>. <pub-id pub-id-type="doi">10.1016/j.carbpol.2014.04.025</pub-id>
<pub-id pub-id-type="pmid">24906778</pub-id>
</citation>
</ref>
<ref id="B32">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Liu</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Tang</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Li</surname>
<given-names>X.</given-names>
</name>
<name>
<surname>Yan</surname>
<given-names>Q.</given-names>
</name>
<name>
<surname>Ma</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Jiang</surname>
<given-names>Z.</given-names>
</name>
</person-group> (<year>2019</year>). <article-title>Curdlan (<italic>Alcaligenes faecalis</italic>) (1&#x2192;3)-&#x3b2;-D-glucan oligosaccharides drive M1 phenotype polarization in murine bone marrow-derived macrophages via activation of MAPKs and NF-&#x3ba;B pathways</article-title>. <source>Molecules</source> <volume>24</volume>, <fpage>4251</fpage>. <pub-id pub-id-type="doi">10.3390/molecules24234251</pub-id>
<pub-id pub-id-type="pmid">31766621</pub-id>
</citation>
</ref>
<ref id="B33">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>McIntosh</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Stone</surname>
<given-names>B. A.</given-names>
</name>
<name>
<surname>Stanisich</surname>
<given-names>V. A.</given-names>
</name>
</person-group> (<year>2005</year>). <article-title>Curdlan and other bacterial (1&#x2192;3)-&#x3b2;-D-glucans</article-title>. <source>Appl. Microbiol. Biotechnol.</source> <volume>68</volume>, <fpage>163</fpage>&#x2013;<lpage>173</lpage>. <pub-id pub-id-type="doi">10.1007/s00253-005-1959-5</pub-id>
<pub-id pub-id-type="pmid">15818477</pub-id>
</citation>
</ref>
<ref id="B34">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Perez</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Makshakova</surname>
<given-names>O.</given-names>
</name>
<name>
<surname>Angulo</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Bedini</surname>
<given-names>E.</given-names>
</name>
<name>
<surname>Bisio</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>de Paz</surname>
<given-names>J. L.</given-names>
</name>
<etal/>
</person-group> (<year>2023</year>). <article-title>Glycosaminoglycans: what remains to be deciphered?</article-title> <source>J. Am. Chem. Soc. Au</source> <volume>3</volume>, <fpage>628</fpage>&#x2013;<lpage>656</lpage>. <pub-id pub-id-type="doi">10.1021/jacsau.2c00569</pub-id>
<pub-id pub-id-type="pmid">37006755</pub-id>
</citation>
</ref>
<ref id="B35">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Prieto</surname>
<given-names>M. A.</given-names>
</name>
<name>
<surname>V&#xe1;zquez</surname>
<given-names>J. A.</given-names>
</name>
<name>
<surname>Murado</surname>
<given-names>M. A.</given-names>
</name>
</person-group> (<year>2011</year>). <article-title>Hydrolysis optimization of mannan, curdlan and cell walls from <italic>Endomyces fibuliger</italic> grown in mussel processing wastewaters</article-title>. <source>Process Biochem.</source> <volume>46</volume>, <fpage>1579</fpage>&#x2013;<lpage>1588</lpage>. <pub-id pub-id-type="doi">10.1016/j.procbio.2011.04.014</pub-id>
</citation>
</ref>
<ref id="B36">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ren</surname>
<given-names>B.</given-names>
</name>
<name>
<surname>Gan</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Zhang</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Yan</surname>
<given-names>N.</given-names>
</name>
<name>
<surname>Dong</surname>
<given-names>H.</given-names>
</name>
</person-group> (<year>2018</year>). <article-title>Diisopropylethylamine-triggered, highly efficient, self-catalyzed regioselective acylation of carbohydrates and diols</article-title>. <source>Org. Biomol. Chem.</source> <volume>16</volume>, <fpage>5591</fpage>&#x2013;<lpage>5597</lpage>. <pub-id pub-id-type="doi">10.1039/C8OB01464G</pub-id>
<pub-id pub-id-type="pmid">30027976</pub-id>
</citation>
</ref>
<ref id="B37">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ricard-Blum</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Viv&#xe8;s</surname>
<given-names>R. R.</given-names>
</name>
<name>
<surname>Schaefer</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>G&#xf6;tte</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Merline</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Passi</surname>
<given-names>A.</given-names>
</name>
<etal/>
</person-group> (<year>2024</year>). <article-title>A biological guide to glycosaminoglycans: current perspectives and pending questions</article-title>. <source>FEBS J.</source> <volume>291</volume>, <fpage>3331</fpage>&#x2013;<lpage>3366</lpage>. <pub-id pub-id-type="doi">10.1111/febs.17107</pub-id>
<pub-id pub-id-type="pmid">38500384</pub-id>
</citation>
</ref>
<ref id="B38">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Sharif</surname>
<given-names>O.</given-names>
</name>
<name>
<surname>Bolshakov</surname>
<given-names>V. N.</given-names>
</name>
<name>
<surname>Raines</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Newham</surname>
<given-names>P.</given-names>
</name>
<name>
<surname>Perkins</surname>
<given-names>N. D.</given-names>
</name>
</person-group> (<year>2007</year>). <article-title>Transcriptional profiling of the LPS induced NF-&#x3ba;B response in macrophages</article-title>. <source>BMC Immunol.</source> <volume>8</volume>, <fpage>1</fpage>. <pub-id pub-id-type="doi">10.1186/1471-2172-8-1</pub-id>
<pub-id pub-id-type="pmid">17222336</pub-id>
</citation>
</ref>
<ref id="B39">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Speciale</surname>
<given-names>I.</given-names>
</name>
<name>
<surname>Notaro</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Garcia-Vello</surname>
<given-names>P.</given-names>
</name>
<name>
<surname>Di Lorenzo</surname>
<given-names>F.</given-names>
</name>
<name>
<surname>Armiento</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Molinaro</surname>
<given-names>A.</given-names>
</name>
<etal/>
</person-group> (<year>2022</year>). <article-title>Liquid-state NMR spectroscopy for complex carbohydrate structural analysis: a hitchhiker&#x2019;s guide</article-title>. <source>Carbohydr. Polym.</source> <volume>277</volume>, <fpage>118885</fpage>. <pub-id pub-id-type="doi">10.1016/j.carbpol.2021.118885</pub-id>
<pub-id pub-id-type="pmid">34893288</pub-id>
</citation>
</ref>
<ref id="B40">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Stothers</surname>
<given-names>C. L.</given-names>
</name>
<name>
<surname>Burelbach</surname>
<given-names>K. R.</given-names>
</name>
<name>
<surname>Owen</surname>
<given-names>A. M.</given-names>
</name>
<name>
<surname>Patil</surname>
<given-names>N. K.</given-names>
</name>
<name>
<surname>McBride</surname>
<given-names>M. A.</given-names>
</name>
<name>
<surname>Bohannon</surname>
<given-names>J. K.</given-names>
</name>
<etal/>
</person-group> (<year>2021</year>). <article-title>&#x3b2;-Glucan induces distinct and protective innate immune memory in differentiated macrophages</article-title>. <source>J. Immunol.</source> <volume>207</volume>, <fpage>2785</fpage>&#x2013;<lpage>2798</lpage>. <pub-id pub-id-type="doi">10.4049/jimmunol.2100107</pub-id>
<pub-id pub-id-type="pmid">34740960</pub-id>
</citation>
</ref>
<ref id="B41">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Vessella</surname>
<given-names>G.</given-names>
</name>
<name>
<surname>Esposito</surname>
<given-names>F.</given-names>
</name>
<name>
<surname>Traboni</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Di Meo</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Iadonisi</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Schiraldi</surname>
<given-names>C.</given-names>
</name>
<etal/>
</person-group> (<year>2021a</year>). <article-title>Exploiting diol reactivity for the access to unprecedented low molecular weight curdlan sulfate polysaccharides</article-title>. <source>Carbohydr. Polym.</source> <volume>269</volume>, <fpage>118324</fpage>. <pub-id pub-id-type="doi">10.1016/j.carbpol.2021.118324</pub-id>
<pub-id pub-id-type="pmid">34294336</pub-id>
</citation>
</ref>
<ref id="B42">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Vessella</surname>
<given-names>G.</given-names>
</name>
<name>
<surname>Marchetti</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Del Prete</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Traboni</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Iadonisi</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Schiraldi</surname>
<given-names>C.</given-names>
</name>
<etal/>
</person-group> (<year>2021b</year>). <article-title>Semisynthetic isomers of fucosylated chondroitin sulfate polysaccharides with fucosyl branches at a non-natural site</article-title>. <source>Biomacromolecules</source> <volume>22</volume>, <fpage>5151</fpage>&#x2013;<lpage>5161</lpage>. <pub-id pub-id-type="doi">10.1021/acs.biomac.1c01112</pub-id>
<pub-id pub-id-type="pmid">34775751</pub-id>
</citation>
</ref>
<ref id="B43">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Wang</surname>
<given-names>Z.</given-names>
</name>
<name>
<surname>Xie</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Shen</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Nie</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Xie</surname>
<given-names>M.</given-names>
</name>
</person-group> (<year>2018</year>). <article-title>Sulfated modification of polysaccharides: synthesis, characterization and bioactivities</article-title>. <source>Trends Food Sci. Technol.</source> <volume>74</volume>, <fpage>147</fpage>&#x2013;<lpage>157</lpage>. <pub-id pub-id-type="doi">10.1016/j.tifs.2018.02.010</pub-id>
</citation>
</ref>
<ref id="B44">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Yoshida</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Yasuda</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Mimura</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Kaneko</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Nakashima</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Yamamoto</surname>
<given-names>N.</given-names>
</name>
<etal/>
</person-group> (<year>1995</year>). <article-title>Synthesis of curdlan sulfates having inhibitory effects in vitro against AIDS viruses HIV-1 and HIV-2</article-title>. <source>Carbohydr. Res.</source> <volume>276</volume>, <fpage>425</fpage>&#x2013;<lpage>436</lpage>. <pub-id pub-id-type="doi">10.1016/0008-6215(95)00186-w</pub-id>
<pub-id pub-id-type="pmid">8542610</pub-id>
</citation>
</ref>
<ref id="B45">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Zeng</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Groth</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Zhang</surname>
<given-names>K.</given-names>
</name>
</person-group> (<year>2019</year>). <article-title>Recent advances in artificially sulfated polysaccharides for applications in cell growth and differentiation, drug delivery, and tissue engineering</article-title>. <source>Chembiochem</source> <volume>20</volume>, <fpage>737</fpage>&#x2013;<lpage>746</lpage>. <pub-id pub-id-type="doi">10.1002/cbic.201800569</pub-id>
<pub-id pub-id-type="pmid">30394659</pub-id>
</citation>
</ref>
<ref id="B46">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Zhan</surname>
<given-names>X.-B.</given-names>
</name>
<name>
<surname>Lin</surname>
<given-names>C.-C.</given-names>
</name>
<name>
<surname>Zhang</surname>
<given-names>H.-T.</given-names>
</name>
</person-group> (<year>2012</year>). <article-title>Recent advances in curdlan biosynthesis, biotechnological production, and applications</article-title>. <source>Appl. Microbiol. Biotechnol.</source> <volume>93</volume>, <fpage>525</fpage>&#x2013;<lpage>531</lpage>. <pub-id pub-id-type="doi">10.1007/s00253-011-3740-2</pub-id>
<pub-id pub-id-type="pmid">22124723</pub-id>
</citation>
</ref>
<ref id="B47">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Zhang</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Edgar</surname>
<given-names>K. J.</given-names>
</name>
</person-group> (<year>2014</year>). <article-title>Properties, chemistry, and applications of the bioactive polysaccharide curdlan</article-title>. <source>Biomacromolecules</source> <volume>15</volume>, <fpage>1079</fpage>&#x2013;<lpage>1096</lpage>. <pub-id pub-id-type="doi">10.1021/bm500038g</pub-id>
<pub-id pub-id-type="pmid">24552241</pub-id>
</citation>
</ref>
</ref-list>
</back>
</article>